<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02315703</url>
  </required_header>
  <id_info>
    <org_study_id>CR106152</org_study_id>
    <secondary_id>HIV-V-A004</secondary_id>
    <secondary_id>IPCAVD009</secondary_id>
    <nct_id>NCT02315703</nct_id>
  </id_info>
  <brief_title>Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention</brief_title>
  <official_title>A Phase 1/2a Trial to Evaluate the Safety/Tolerability and Immunogenicity of Homologous Ad26 Mosaic Vector Regimens or Ad26 Mosaic and MVA Mosaic Heterologous Vector Regimens, With High-Dose, Low-Dose or no Clade C gp140 Protein Plus Adjuvant for HIV Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Janssen Vaccines &amp; Prevention B.V.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>US Military HIV Research Program</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International AIDS Vaccine Initiative</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Janssen Vaccines &amp; Prevention B.V.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and tolerability of various regimens&#xD;
      containing adenovirus serotype 26-Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV),&#xD;
      Modified Vaccinia Ankara (MVA)-Mosaic, and/or HIV type 1 Clade C glycoprotein 140 drug&#xD;
      product (gp140 DP) components and to compare envelope binding antibody responses between the&#xD;
      different vaccine regimens.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter (more than 1 hospital or medical school team work on a study),&#xD;
      randomized (the study drug is assigned by chance), parallel group (each group of participants&#xD;
      will be treated at the same time), placebo-controlled (study in which the experimental&#xD;
      treatment or procedure is compared to a pretend treatment with no drug in it to test if the&#xD;
      drug has a real effect), and double-blind (neither physician nor participant knows the&#xD;
      treatment that the participant receives) study. All eligible participants will be randomly&#xD;
      assigned to receive 1 of the 8 vaccine regimens. Participants will receive study vaccines&#xD;
      (Ad26.Mos.HIV, MVA-Mosaic, gp140 DP, and placebo) 4 times as per assigned regimen. The study&#xD;
      comprises a Screening Period (up to 4 weeks), a Vaccination Period (participants will be&#xD;
      vaccinated at Baseline (Week 0), Week 12, Week 24 and Week 48), and a Follow-up Period (up to&#xD;
      48 weeks). A long-term follow-up period (approximately 2 years after Week 96) will continue&#xD;
      for participants randomized to the regimen subsequently selected for future studies, based on&#xD;
      analysis of Week 28 data. If Week 28 data are inconclusive, Week 52 data will be considered&#xD;
      for regimen selection. If no clear decision can be made, the extended follow-up period could&#xD;
      include participants from more than 1 group for assessing durability of immune responses.&#xD;
      Participants' safety will be monitored throughout the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 2014</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Actual">August 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of Participants With Solicited Local Adverse Events (AEs) Post Vaccination</measure>
    <time_frame>Up to Week 49 (7 days post any dose)</time_frame>
    <description>Solicited local AEs (at injection site) included erythema, induration, swelling, itching and warmth were collected within 7 days after vaccination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants With Solicited Systemic Adverse Events (AEs) Post Vaccination</measure>
    <time_frame>Up to Week 49 (7 days post any dose)</time_frame>
    <description>Solicited systemic AEs included fever (defined as body temperature of 38.0-degree celsius or higher), headache, fatigue, myalgia, nausea, vomiting were collected within 7 days after vaccination.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants With Unsolicited Adverse Events Post Vaccination</measure>
    <time_frame>Up to Week 52 (28 days post vaccination)</time_frame>
    <description>Unsolicited AEs were defined as events that participants experienced but were not specifically asked about.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Serious Adverse Events (SAEs) Post Vaccination</measure>
    <time_frame>Up to Week 96</time_frame>
    <description>An AE is any untoward medical occurrence in a clinical study participant administered a medicinal (investigational or non-investigational) product. An AE does not necessarily have a causal relationship with the study vaccine. An AE can be any unfavorable and unintended sign (including an abnormal finding), symptom, or disease temporally associated with the use of a medicinal (investigational or non-investigational) product, whether or not related to that medicinal (investigational or non-investigational) product. A SAE is any AE that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect and is a suspected transmission of any infectious agent via a medicinal product.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Responders for Envelop (Env) Clade A, B and C-specific Binding Antibody Titers at Week 28</measure>
    <time_frame>Week 28</time_frame>
    <description>The Env Clade A (92UG037.1), B (1990a), and C (Con C), (C97ZA.012)- specific binding antibody titer were assessed using enzyme-linked immunosorbent assay (ELISA). The response was defined as post-baseline value greater than (&gt;) lower limit of quantification (LLOQ) if baseline less than (&lt;) LLOQ or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline greater than or equal to (&gt;=) LLOQ. The lower limits of quantification (LLOQs) for this assay were 625, 156.25, 625, and 156.25 endotoxin units per milliliter (EU/mL) for Clade A (92UG037.1), Clade B (1990a), Clade C (Con C), and Clade C (C97ZA.012) respectively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Responders for Clade C (C97ZA.012) Env Enzyme-linked Immunosorbent Assay (ELISA) Immunoglobulin G1 (IgG1), IgG2, IgG3 and IgG4 Gylcoprotein (gp) 140 Binding Antibody</measure>
    <time_frame>Week 28, 52 and 96</time_frame>
    <description>Vaccine-induced binding antibody IgG1, IgG2, IgG3 and IgG4 subclass responses were investigated using Clade C (C97ZA.012) specific ELISAs. The response was defined as post-baseline value &gt;LLOQ if baseline &lt;LLOQ or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=LLOQ. The LLOQs for this assay were 12.3, 28.7, 12.4, and 13.2 for IgG1, IgG2, IgG3 and IgG4 respectively. Samples taken after Week 48 (W48) from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Responders for Env ELISA Including Consensus C and Mos1 Antigens</measure>
    <time_frame>Week 28, 52 and 96</time_frame>
    <description>The response was defined as post-baseline value &gt;LLOQ if baseline &lt;LLOQ or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=LLOQ. The LLOQ for this assay is a 50 percent (%) inhibitory concentration (IC50) of 20 (fold-dilution). The lower limits of quantification (LLOQs) for this assay were 625 and 78.125 EU/mL for Clade C (Con C) and Mos1 respectively. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Responders for Env Antibody-dependent Cellular Phagocytosis (ADCP) gp Antibody</measure>
    <time_frame>Week 16, 26, 28, 52, 78, and 96</time_frame>
    <description>The functionality of vaccine-induced antibody responses was investigated by the determination of ADCP. The response was defined as post-baseline value &gt; limit of detection (LOD) if baseline &lt;LOD or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=LOD. The lower limits of detection (LODs) for this assay were 5.16, 6.43, 6.49, 4.32 and 4.28 (phagocytic score) for Clade A (92UG037.1), Clade B (1990a), Clade C (Con C), Clade C (C97ZA.012), and Mos1, respectively. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category of Clade A, B, C and Mos 1.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Responders for Human Immunodeficiency Virus Neutralizing Antibody (HIV nAb)</measure>
    <time_frame>Week 28 and 52</time_frame>
    <description>The functionality of vaccine-induced antibody responses was investigated by the determination of nAb activity in a virus neutralization assay (VNA) using TZM-bl cells and Env-pseudotyped viruses. The response was defined as post-baseline value &gt;LLOQ. The LLOQ for this assay is an inhibitory concentration (IC50) of 20 (fold-dilution). Data reported for the responses against Tier 1 HIV strain Clade C (MW965.26) was reported. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Responders for Binding Antibody Multiplex Assay (BAMA) IgG1-IgG4 and IgA and IgG-t Breadth Antibody</measure>
    <time_frame>Week 16, 28, 52, 78, and 96</time_frame>
    <description>The human immunodeficiency virus (HIV)-1 BAMA employs flow-cytometric-based technology that also utilizes antibody and antigen interactions to test for the presence of specific antibodies in an unknown sample with the added advantage of multiplexing the antigens of interest. Positive and negative control standards were run with each assay to ensure specificity. The positivity threshold was determined per antigen based on the plus (+) 3 standard deviation (SD) on the non-specific background. Sample values had to be greater than or equal to this value and had to be 3-fold over the baseline values with a minimum median fluorescent intensities (MFI) value of 100. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Responders With Interferon-gamma (IFN-gamma) T Cell Responses Enzyme-linked Immunospot Assay (ELISpot)</measure>
    <time_frame>Week 26, 50, 78 and 96</time_frame>
    <description>Frozen peripheral blood mononuclear cell (PBMCs) were analyzed by interferon-gamma (IFN-gamma) (ELISpot). The response was defined as post-baseline value &gt;P95 if baseline &lt;P95 or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=P95. The threshold for ELISpot test was based on the 95th percentile (P95) from the baseline values of participants on that test in the study. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">393</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive adenovirus serotype 26-Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) vaccine at Week 0 and 12; followed by Ad26.Mos.HIV vaccine + HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) vaccine containing 250 microgram (mcg) of total protein mixed with adjuvant (aluminum phosphate) at Week 24 and 48.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive Ad26.Mos.HIV vaccine at Week 0 and 12; followed by Ad26.Mos.HIV vaccine + gp140 DP vaccine containing 50 mcg of total protein mixed with adjuvant at Week 24 and 48.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive Ad26.Mos.HIV vaccine at Week 0 and 12; followed by Ad26.Mos.HIV vaccine + placebo injection at Week 24 and 48.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive Ad26.Mos.HIV vaccine at Week 0 and 12; followed by modified Vaccinia Ankara (MVA)-Mosaic vaccine + gp140 DP vaccine containing 250 mcg of total protein mixed with adjuvant at Week 24 and 48.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive Ad26.Mos.HIV vaccine at Week 0 and 12; followed by MVA-Mosaic vaccine + gp140 DP vaccine containing 50 mcg of total protein mixed with adjuvant at Week 24 and 48.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive Ad26.Mos.HIV vaccine at Week 0 and 12; followed by MVA-Mosaic vaccine + placebo injection at Week 24 and 48.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 7</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive Ad26.Mos.HIV vaccine at Week 0 and 12; followed by gp140 DP vaccine containing 250 mcg of total protein mixed with adjuvant + placebo injection at Week 24 and 48.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 8</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive 1 placebo injection at Week 0 and 12; followed by 2 placebo injections at Week 24 and 48.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Ad26.Mos.HIV</intervention_name>
    <description>Recombinant replication-deficient Ad26 vectored vaccine and consists of 3 Ad26 vectors, one containing a mosaic insert of envelop (Env) sequence, and 2 vectors containing mosaic inserts of Gag and Pol sequences (Ad26.Mos.1.Env + Ad26.Mos1.Gag-Pol + Ad26.Mos2.Gag-Pol). Total dose is 5*10^10 viral particle per 0.5 milliliter (mL) injection administered intramuscularly.</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_label>Group 6</arm_group_label>
    <arm_group_label>Group 7</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>MVA-Mosaic</intervention_name>
    <description>Recombinant live attenuated MVA virus-vectored vaccine that has been genetically engineered to express 2 mosaic Gag, Pol, and Env sequences (Mosaic 1 and Mosaic 2). Total dose is 10^8 plaque-forming unit per 0.5 mL injection administered intramuscularly.</description>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_label>Group 5</arm_group_label>
    <arm_group_label>Group 6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>gp140 DP Low-dose</intervention_name>
    <description>The gp140 DP vaccine containing 50 mcg of total protein, mixed with aluminum phosphate adjuvant (0.425 mg aluminum), per 0.5 mL injection administered intramuscularly.</description>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 5</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>gp140 DP High-dose</intervention_name>
    <description>The gp140 DP vaccine containing 250 mcg of total protein, mixed with aluminum phosphate adjuvant, per 0.5 mL injection administered intramuscularly.</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_label>Group 7</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Normal saline, 0.5 mL injection administered intramuscularly.</description>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 6</arm_group_label>
    <arm_group_label>Group 7</arm_group_label>
    <arm_group_label>Group 8</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participant must be healthy on the basis of physical examination, medical history,&#xD;
             electrocardiogram (ECG) and laboratory criteria, and vital signs measurement performed&#xD;
             at Screening&#xD;
&#xD;
          -  Participants are negative for human immunodeficiency virus (HIV) infection at&#xD;
             Screening&#xD;
&#xD;
          -  All female participants of childbearing potential must have a negative serum (beta&#xD;
             human chorionic gonadotropin) at Screening, and a negative urine pregnancy test&#xD;
             pre-dose on Week 0, 12, 24, and 48&#xD;
&#xD;
          -  A woman must agree not to donate eggs (ova, oocytes) for the purposes of assisted&#xD;
             reproduction until 3 months after receiving the last dose of study vaccine. A man must&#xD;
             agree not to donate sperm until 3 months after receiving the last dose of study&#xD;
             vaccine&#xD;
&#xD;
          -  Participants are assessed by the clinic staff as being at low risk for HIV infection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participant has chronic active hepatitis B or active hepatitis C, active syphilis&#xD;
             infection, chlamydia, gonorrhea, or trichomonas. Active syphilis documented by exam or&#xD;
             serology unless positive serology is due to past treated infection&#xD;
&#xD;
          -  In the 12 months prior to enrollment, participant has a history of newly acquired&#xD;
             herpes simplex virus type 2 (HSV-2), syphilis, gonorrhea, non-gonococcal urethritis,&#xD;
             chlamydia, pelvic inflammatory disease, trichomonas, mucopurulent cervicitis,&#xD;
             epididymitis, proctitis, lymphogranulomavenereum, chancroid, or hepatitis B&#xD;
&#xD;
          -  Participant has any clinically significant acute or chronic medical condition that in&#xD;
             the opinion of the investigator would preclude participation (for example, history of&#xD;
             seizure disorders, bleeding/clotting disorder, autoimmune disease, active malignancy,&#xD;
             poorly controlled asthma, active tuberculosis or other systemic infections)&#xD;
&#xD;
          -  Participant has had major surgery within the 4 weeks prior to study entry or planned&#xD;
             major surgery through the course of the study&#xD;
&#xD;
          -  Participant has had a thyroidectomy, or thyroid disease requiring medication during&#xD;
             the last 12 months&#xD;
&#xD;
          -  Participant has a history of myocarditis, pericarditis, cardiomyopathy, congestive&#xD;
             heart failure with permanent sequelae, clinically significant arrhythmia (including&#xD;
             any arrhythmia requiring medication, treatment, or clinical follow up)&#xD;
&#xD;
          -  Participant has an ECG (per examination and interpretation of a cardiologist) with&#xD;
             clinically significant findings, or features that would interfere with the assessment&#xD;
             of myo/pericarditis, including any of the following: a) conduction disturbance&#xD;
             (complete left or complete right bundle branch block or nonspecific intraventricular&#xD;
             conduction disturbance with QRS &gt;=120 millisecond [ms], PR interval &gt;=220 ms, any 2nd&#xD;
             or 3rd degree AV block, or QTc prolongation [&gt;450 ms]); b) significant repolarization&#xD;
             (ST segment or T wave) abnormality; c) significant atrial or ventricular arrhythmia,&#xD;
             frequent atrial or ventricular ectopy (for example frequent premature atrial&#xD;
             contractions, 2 premature ventricular contractions in a row); d) ST elevation&#xD;
             consistent with ischemia, or evidence of past or evolving myocardial infarction&#xD;
&#xD;
          -  Participant has a history of anaphylaxis or other serious adverse reactions to&#xD;
             vaccines or vaccine products, or neomycin or streptomycin or egg products&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Janssen Vaccines &amp; Prevention B.V. Clinical Trials</last_name>
    <role>Study Director</role>
    <affiliation>Janssen Vaccines &amp; Prevention B.V.</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kigali</city>
        <country>Rwanda</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cape Town</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Durban</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Johannesburg</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Entebbe</city>
        <country>Uganda</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Kampala</city>
        <country>Uganda</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Rwanda</country>
    <country>South Africa</country>
    <country>Thailand</country>
    <country>Uganda</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>December 9, 2014</study_first_submitted>
  <study_first_submitted_qc>December 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2014</study_first_posted>
  <results_first_submitted>August 28, 2020</results_first_submitted>
  <results_first_submitted_qc>October 13, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 4, 2020</results_first_posted>
  <disposition_first_submitted>February 1, 2017</disposition_first_submitted>
  <disposition_first_submitted_qc>February 1, 2017</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">February 2, 2017</disposition_first_posted>
  <last_update_submitted>October 26, 2021</last_update_submitted>
  <last_update_submitted_qc>October 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy</keyword>
  <keyword>Acquired Immuno-Deficiency Syndrome</keyword>
  <keyword>Acquired Immunodeficiency Syndrome Virus</keyword>
  <keyword>adenovirus serotype 26</keyword>
  <keyword>Ad26.Mos.HIV</keyword>
  <keyword>Modified Vaccinia Ankara</keyword>
  <keyword>Glycoprotein</keyword>
  <keyword>Adjuvant</keyword>
  <keyword>Vaccine</keyword>
  <keyword>Placebo</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 21, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/03/NCT02315703/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 15, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/03/NCT02315703/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
          <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
        </group>
        <group group_id="P2">
          <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
        </group>
        <group group_id="P3">
          <title>Group 3: Ad26/Ad26</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
        </group>
        <group group_id="P4">
          <title>Group 4: Ad26/MVA + gp140 HD</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
        </group>
        <group group_id="P5">
          <title>Group 5: Ad26/ MVA + gp140 LD</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
        </group>
        <group group_id="P6">
          <title>Group 6: Ad26/MVA</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
        </group>
        <group group_id="P7">
          <title>Group 7: Ad26/ gp140 HD</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
        </group>
        <group group_id="P8">
          <title>Group 8: Placebo/ Placebo</title>
          <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="49"/>
                <participants group_id="P3" count="49"/>
                <participants group_id="P4" count="48"/>
                <participants group_id="P5" count="49"/>
                <participants group_id="P6" count="49"/>
                <participants group_id="P7" count="50"/>
                <participants group_id="P8" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="39"/>
                <participants group_id="P3" count="44"/>
                <participants group_id="P4" count="39"/>
                <participants group_id="P5" count="41"/>
                <participants group_id="P6" count="43"/>
                <participants group_id="P7" count="37"/>
                <participants group_id="P8" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="10"/>
                <participants group_id="P3" count="5"/>
                <participants group_id="P4" count="9"/>
                <participants group_id="P5" count="8"/>
                <participants group_id="P6" count="6"/>
                <participants group_id="P7" count="13"/>
                <participants group_id="P8" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="2"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="2"/>
                <participants group_id="P8" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pregnancy</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="4"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Other</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="1"/>
                <participants group_id="P6" count="2"/>
                <participants group_id="P7" count="8"/>
                <participants group_id="P8" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
          <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
        </group>
        <group group_id="B2">
          <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
        </group>
        <group group_id="B3">
          <title>Group 3: Ad26/Ad26</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
        </group>
        <group group_id="B4">
          <title>Group 4: Ad26/MVA + gp140 HD</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
        </group>
        <group group_id="B5">
          <title>Group 5: Ad26/ MVA + gp140 LD</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
        </group>
        <group group_id="B6">
          <title>Group 6: Ad26/MVA</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
        </group>
        <group group_id="B7">
          <title>Group 7: Ad26/ gp140 HD</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
        </group>
        <group group_id="B8">
          <title>Group 8: Placebo/ Placebo</title>
          <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
        </group>
        <group group_id="B9">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="49"/>
            <count group_id="B3" value="49"/>
            <count group_id="B4" value="48"/>
            <count group_id="B5" value="49"/>
            <count group_id="B6" value="49"/>
            <count group_id="B7" value="50"/>
            <count group_id="B8" value="49"/>
            <count group_id="B9" value="393"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.8" spread="7.77"/>
                    <measurement group_id="B2" value="29.6" spread="7.49"/>
                    <measurement group_id="B3" value="31.1" spread="8.22"/>
                    <measurement group_id="B4" value="29.6" spread="7.67"/>
                    <measurement group_id="B5" value="30.3" spread="7.61"/>
                    <measurement group_id="B6" value="29.2" spread="8.73"/>
                    <measurement group_id="B7" value="30.3" spread="7.65"/>
                    <measurement group_id="B8" value="29" spread="8.06"/>
                    <measurement group_id="B9" value="29.9" spread="7.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="28"/>
                    <measurement group_id="B4" value="19"/>
                    <measurement group_id="B5" value="25"/>
                    <measurement group_id="B6" value="19"/>
                    <measurement group_id="B7" value="19"/>
                    <measurement group_id="B8" value="20"/>
                    <measurement group_id="B9" value="181"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="29"/>
                    <measurement group_id="B5" value="24"/>
                    <measurement group_id="B6" value="30"/>
                    <measurement group_id="B7" value="31"/>
                    <measurement group_id="B8" value="29"/>
                    <measurement group_id="B9" value="212"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="6"/>
                    <measurement group_id="B5" value="3"/>
                    <measurement group_id="B6" value="5"/>
                    <measurement group_id="B7" value="3"/>
                    <measurement group_id="B8" value="6"/>
                    <measurement group_id="B9" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="43"/>
                    <measurement group_id="B3" value="46"/>
                    <measurement group_id="B4" value="42"/>
                    <measurement group_id="B5" value="46"/>
                    <measurement group_id="B6" value="44"/>
                    <measurement group_id="B7" value="47"/>
                    <measurement group_id="B8" value="43"/>
                    <measurement group_id="B9" value="357"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="1"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="8"/>
                    <measurement group_id="B7" value="8"/>
                    <measurement group_id="B8" value="9"/>
                    <measurement group_id="B9" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="27"/>
                    <measurement group_id="B5" value="26"/>
                    <measurement group_id="B6" value="26"/>
                    <measurement group_id="B7" value="32"/>
                    <measurement group_id="B8" value="25"/>
                    <measurement group_id="B9" value="219"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="15"/>
                    <measurement group_id="B6" value="13"/>
                    <measurement group_id="B7" value="9"/>
                    <measurement group_id="B8" value="15"/>
                    <measurement group_id="B9" value="104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>RWANDA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="5"/>
                    <measurement group_id="B8" value="6"/>
                    <measurement group_id="B9" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SOUTH AFRICA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="5"/>
                    <measurement group_id="B6" value="7"/>
                    <measurement group_id="B7" value="9"/>
                    <measurement group_id="B8" value="6"/>
                    <measurement group_id="B9" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>THAILAND</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="7"/>
                    <measurement group_id="B7" value="8"/>
                    <measurement group_id="B8" value="7"/>
                    <measurement group_id="B9" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>UGANDA</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="8"/>
                    <measurement group_id="B5" value="9"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="9"/>
                    <measurement group_id="B8" value="11"/>
                    <measurement group_id="B9" value="71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>UNITED STATES</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="18"/>
                    <measurement group_id="B5" value="19"/>
                    <measurement group_id="B6" value="19"/>
                    <measurement group_id="B7" value="19"/>
                    <measurement group_id="B8" value="19"/>
                    <measurement group_id="B9" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With Solicited Local Adverse Events (AEs) Post Vaccination</title>
        <description>Solicited local AEs (at injection site) included erythema, induration, swelling, itching and warmth were collected within 7 days after vaccination.</description>
        <time_frame>Up to Week 49 (7 days post any dose)</time_frame>
        <population>The FAS included all randomized participants with at least one study vaccine administration documented regardless of the occurrence of protocol deviations.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Solicited Local Adverse Events (AEs) Post Vaccination</title>
          <description>Solicited local AEs (at injection site) included erythema, induration, swelling, itching and warmth were collected within 7 days after vaccination.</description>
          <population>The FAS included all randomized participants with at least one study vaccine administration documented regardless of the occurrence of protocol deviations.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="49"/>
                <count group_id="O4" value="48"/>
                <count group_id="O5" value="49"/>
                <count group_id="O6" value="49"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.0"/>
                    <measurement group_id="O2" value="83.7"/>
                    <measurement group_id="O3" value="75.5"/>
                    <measurement group_id="O4" value="77.1"/>
                    <measurement group_id="O5" value="77.6"/>
                    <measurement group_id="O6" value="77.6"/>
                    <measurement group_id="O7" value="70.0"/>
                    <measurement group_id="O8" value="57.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With Solicited Systemic Adverse Events (AEs) Post Vaccination</title>
        <description>Solicited systemic AEs included fever (defined as body temperature of 38.0-degree celsius or higher), headache, fatigue, myalgia, nausea, vomiting were collected within 7 days after vaccination.</description>
        <time_frame>Up to Week 49 (7 days post any dose)</time_frame>
        <population>The FAS included all randomized participants with at least one study vaccine administration documented regardless of the occurrence of protocol deviations.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Solicited Systemic Adverse Events (AEs) Post Vaccination</title>
          <description>Solicited systemic AEs included fever (defined as body temperature of 38.0-degree celsius or higher), headache, fatigue, myalgia, nausea, vomiting were collected within 7 days after vaccination.</description>
          <population>The FAS included all randomized participants with at least one study vaccine administration documented regardless of the occurrence of protocol deviations.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="49"/>
                <count group_id="O4" value="48"/>
                <count group_id="O5" value="49"/>
                <count group_id="O6" value="49"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.0"/>
                    <measurement group_id="O2" value="85.7"/>
                    <measurement group_id="O3" value="73.5"/>
                    <measurement group_id="O4" value="75.0"/>
                    <measurement group_id="O5" value="87.8"/>
                    <measurement group_id="O6" value="73.5"/>
                    <measurement group_id="O7" value="62.0"/>
                    <measurement group_id="O8" value="59.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Participants With Unsolicited Adverse Events Post Vaccination</title>
        <description>Unsolicited AEs were defined as events that participants experienced but were not specifically asked about.</description>
        <time_frame>Up to Week 52 (28 days post vaccination)</time_frame>
        <population>The FAS included all randomized participants with at least one study vaccine administration documented regardless of the occurrence of protocol deviations.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Participants With Unsolicited Adverse Events Post Vaccination</title>
          <description>Unsolicited AEs were defined as events that participants experienced but were not specifically asked about.</description>
          <population>The FAS included all randomized participants with at least one study vaccine administration documented regardless of the occurrence of protocol deviations.</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="49"/>
                <count group_id="O4" value="48"/>
                <count group_id="O5" value="49"/>
                <count group_id="O6" value="49"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.0"/>
                    <measurement group_id="O2" value="73.5"/>
                    <measurement group_id="O3" value="85.7"/>
                    <measurement group_id="O4" value="87.5"/>
                    <measurement group_id="O5" value="69.4"/>
                    <measurement group_id="O6" value="83.7"/>
                    <measurement group_id="O7" value="86.0"/>
                    <measurement group_id="O8" value="77.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Serious Adverse Events (SAEs) Post Vaccination</title>
        <description>An AE is any untoward medical occurrence in a clinical study participant administered a medicinal (investigational or non-investigational) product. An AE does not necessarily have a causal relationship with the study vaccine. An AE can be any unfavorable and unintended sign (including an abnormal finding), symptom, or disease temporally associated with the use of a medicinal (investigational or non-investigational) product, whether or not related to that medicinal (investigational or non-investigational) product. A SAE is any AE that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect and is a suspected transmission of any infectious agent via a medicinal product.</description>
        <time_frame>Up to Week 96</time_frame>
        <population>The FAS included all randomized participants with at least one study vaccine administration documented regardless of the occurrence of protocol deviations.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Serious Adverse Events (SAEs) Post Vaccination</title>
          <description>An AE is any untoward medical occurrence in a clinical study participant administered a medicinal (investigational or non-investigational) product. An AE does not necessarily have a causal relationship with the study vaccine. An AE can be any unfavorable and unintended sign (including an abnormal finding), symptom, or disease temporally associated with the use of a medicinal (investigational or non-investigational) product, whether or not related to that medicinal (investigational or non-investigational) product. A SAE is any AE that results in death, is life-threatening, requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent or significant disability/incapacity, is a congenital anomaly/birth defect and is a suspected transmission of any infectious agent via a medicinal product.</description>
          <population>The FAS included all randomized participants with at least one study vaccine administration documented regardless of the occurrence of protocol deviations.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="49"/>
                <count group_id="O3" value="49"/>
                <count group_id="O4" value="48"/>
                <count group_id="O5" value="49"/>
                <count group_id="O6" value="49"/>
                <count group_id="O7" value="50"/>
                <count group_id="O8" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="2"/>
                    <measurement group_id="O3" value="3"/>
                    <measurement group_id="O4" value="4"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="5"/>
                    <measurement group_id="O7" value="2"/>
                    <measurement group_id="O8" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Responders for Envelop (Env) Clade A, B and C-specific Binding Antibody Titers at Week 28</title>
        <description>The Env Clade A (92UG037.1), B (1990a), and C (Con C), (C97ZA.012)- specific binding antibody titer were assessed using enzyme-linked immunosorbent assay (ELISA). The response was defined as post-baseline value greater than (&gt;) lower limit of quantification (LLOQ) if baseline less than (&lt;) LLOQ or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline greater than or equal to (&gt;=) LLOQ. The lower limits of quantification (LLOQs) for this assay were 625, 156.25, 625, and 156.25 endotoxin units per milliliter (EU/mL) for Clade A (92UG037.1), Clade B (1990a), Clade C (Con C), and Clade C (C97ZA.012) respectively.</description>
        <time_frame>Week 28</time_frame>
        <population>Per protocol immunogenicity (PPI) analysis set: participants who received at least first 3 vaccines as scheduled, had at least 1 post-vaccination immunogenicity blood draw and not diagnosed with HIV. N(number of participants analyzed): participants who were evaluable for this OM. n(number analyzed): participants evaluable for specified categories.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Responders for Envelop (Env) Clade A, B and C-specific Binding Antibody Titers at Week 28</title>
          <description>The Env Clade A (92UG037.1), B (1990a), and C (Con C), (C97ZA.012)- specific binding antibody titer were assessed using enzyme-linked immunosorbent assay (ELISA). The response was defined as post-baseline value greater than (&gt;) lower limit of quantification (LLOQ) if baseline less than (&lt;) LLOQ or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline greater than or equal to (&gt;=) LLOQ. The lower limits of quantification (LLOQs) for this assay were 625, 156.25, 625, and 156.25 endotoxin units per milliliter (EU/mL) for Clade A (92UG037.1), Clade B (1990a), Clade C (Con C), and Clade C (C97ZA.012) respectively.</description>
          <population>Per protocol immunogenicity (PPI) analysis set: participants who received at least first 3 vaccines as scheduled, had at least 1 post-vaccination immunogenicity blood draw and not diagnosed with HIV. N(number of participants analyzed): participants who were evaluable for this OM. n(number analyzed): participants evaluable for specified categories.</population>
          <units>percentage of responders</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="44"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="42"/>
                <count group_id="O7" value="44"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Clade A (92UG037.1)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="92.6" upper_limit="100"/>
                    <measurement group_id="O2" value="97.6" lower_limit="87.14" upper_limit="99.94"/>
                    <measurement group_id="O3" value="97.8" lower_limit="88.47" upper_limit="99.94"/>
                    <measurement group_id="O4" value="95.5" lower_limit="84.53" upper_limit="99.44"/>
                    <measurement group_id="O5" value="97.7" lower_limit="87.71" upper_limit="99.94"/>
                    <measurement group_id="O6" value="97.6" lower_limit="87.43" upper_limit="99.94"/>
                    <measurement group_id="O7" value="95.5" lower_limit="84.53" upper_limit="99.44"/>
                    <measurement group_id="O8" value="2.2" lower_limit="0.06" upper_limit="11.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (1990a)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="42"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="92.6" upper_limit="100"/>
                    <measurement group_id="O2" value="100.0" lower_limit="91.4" upper_limit="100"/>
                    <measurement group_id="O3" value="100.0" lower_limit="92.29" upper_limit="100"/>
                    <measurement group_id="O4" value="100.0" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O5" value="100.0" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O6" value="100.0" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O7" value="100.0" lower_limit="91.96" upper_limit="100"/>
                    <measurement group_id="O8" value="6.5" lower_limit="1.37" upper_limit="17.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (Con C)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="92.45" upper_limit="100"/>
                    <measurement group_id="O2" value="100.0" lower_limit="91.4" upper_limit="100"/>
                    <measurement group_id="O3" value="100.0" lower_limit="92.29" upper_limit="100"/>
                    <measurement group_id="O4" value="95.5" lower_limit="84.53" upper_limit="99.44"/>
                    <measurement group_id="O5" value="100.0" lower_limit="91.78" upper_limit="100"/>
                    <measurement group_id="O6" value="100.0" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O7" value="97.7" lower_limit="87.98" upper_limit="99.94"/>
                    <measurement group_id="O8" value="6.5" lower_limit="1.37" upper_limit="17.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="92.6" upper_limit="100"/>
                    <measurement group_id="O2" value="100" lower_limit="91.4" upper_limit="100"/>
                    <measurement group_id="O3" value="100" lower_limit="92.29" upper_limit="100"/>
                    <measurement group_id="O4" value="97.7" lower_limit="87.98" upper_limit="99.94"/>
                    <measurement group_id="O5" value="100" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O6" value="100" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O7" value="100" lower_limit="91.96" upper_limit="100"/>
                    <measurement group_id="O8" value="2.2" lower_limit="0.06" upper_limit="11.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Responders for Clade C (C97ZA.012) Env Enzyme-linked Immunosorbent Assay (ELISA) Immunoglobulin G1 (IgG1), IgG2, IgG3 and IgG4 Gylcoprotein (gp) 140 Binding Antibody</title>
        <description>Vaccine-induced binding antibody IgG1, IgG2, IgG3 and IgG4 subclass responses were investigated using Clade C (C97ZA.012) specific ELISAs. The response was defined as post-baseline value &gt;LLOQ if baseline &lt;LLOQ or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=LLOQ. The LLOQs for this assay were 12.3, 28.7, 12.4, and 13.2 for IgG1, IgG2, IgG3 and IgG4 respectively. Samples taken after Week 48 (W48) from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
        <time_frame>Week 28, 52 and 96</time_frame>
        <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Responders for Clade C (C97ZA.012) Env Enzyme-linked Immunosorbent Assay (ELISA) Immunoglobulin G1 (IgG1), IgG2, IgG3 and IgG4 Gylcoprotein (gp) 140 Binding Antibody</title>
          <description>Vaccine-induced binding antibody IgG1, IgG2, IgG3 and IgG4 subclass responses were investigated using Clade C (C97ZA.012) specific ELISAs. The response was defined as post-baseline value &gt;LLOQ if baseline &lt;LLOQ or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=LLOQ. The LLOQs for this assay were 12.3, 28.7, 12.4, and 13.2 for IgG1, IgG2, IgG3 and IgG4 respectively. Samples taken after Week 48 (W48) from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
          <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
          <units>percentage of responders</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="42"/>
                <count group_id="O6" value="40"/>
                <count group_id="O7" value="44"/>
                <count group_id="O8" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Clade C (C97ZA.012) IgG1 at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.7" lower_limit="64.34" upper_limit="89.3"/>
                    <measurement group_id="O2" value="80.5" lower_limit="65.13" upper_limit="91.18"/>
                    <measurement group_id="O3" value="50.0" lower_limit="34.9" upper_limit="65.1"/>
                    <measurement group_id="O4" value="82.2" lower_limit="67.95" upper_limit="92"/>
                    <measurement group_id="O5" value="61.9" lower_limit="45.64" upper_limit="76.43"/>
                    <measurement group_id="O6" value="67.5" lower_limit="50.87" upper_limit="81.43"/>
                    <measurement group_id="O7" value="81.8" lower_limit="67.29" upper_limit="91.81"/>
                    <measurement group_id="O8" value="0.0" lower_limit="0.0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) IgG1 at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="38"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.8" lower_limit="67.29" upper_limit="91.81"/>
                    <measurement group_id="O2" value="94.7" lower_limit="82.25" upper_limit="99.36"/>
                    <measurement group_id="O3" value="59.5" lower_limit="43.28" upper_limit="74.37"/>
                    <measurement group_id="O4" value="82.9" lower_limit="67.94" upper_limit="92.85"/>
                    <measurement group_id="O5" value="71.8" lower_limit="55.13" upper_limit="85"/>
                    <measurement group_id="O6" value="72.5" lower_limit="56.11" upper_limit="85.4"/>
                    <measurement group_id="O7" value="89.5" lower_limit="75.2" upper_limit="97.06"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) IgG1 at Week 96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="23"/>
                    <count group_id="O4" value="21"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="25"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.6" lower_limit="22.12" upper_limit="53.06"/>
                    <measurement group_id="O2" value="26.3" lower_limit="13.4" upper_limit="43.1"/>
                    <measurement group_id="O3" value="4.3" lower_limit="0.11" upper_limit="21.95"/>
                    <measurement group_id="O4" value="38.1" lower_limit="18.11" upper_limit="61.56"/>
                    <measurement group_id="O5" value="16.7" lower_limit="4.74" upper_limit="37.38"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="13.72"/>
                    <measurement group_id="O7" value="50.0" lower_limit="29.12" upper_limit="70.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) IgG2 at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.55"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O3" value="2.2" lower_limit="0.06" upper_limit="11.53"/>
                    <measurement group_id="O4" value="2.2" lower_limit="0.06" upper_limit="11.77"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.06" upper_limit="12.57"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="2.3" lower_limit="0.06" upper_limit="12.02"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) IgG2 at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="38"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" lower_limit="0.06" upper_limit="12.29"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="9.25"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O4" value="4.9" lower_limit="0.6" upper_limit="16.53"/>
                    <measurement group_id="O5" value="7.7" lower_limit="1.62" upper_limit="20.87"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="7.9" lower_limit="1.66" upper_limit="21.38"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) IgG3 at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="41"/>
                    <count group_id="O6" value="39"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.7" lower_limit="30.17" upper_limit="59.88"/>
                    <measurement group_id="O2" value="29.3" lower_limit="16.13" upper_limit="45.54"/>
                    <measurement group_id="O3" value="10.9" lower_limit="3.62" upper_limit="23.57"/>
                    <measurement group_id="O4" value="47.7" lower_limit="32.46" upper_limit="63.31"/>
                    <measurement group_id="O5" value="29.3" lower_limit="16.13" upper_limit="45.54"/>
                    <measurement group_id="O6" value="20.5" lower_limit="9.3" upper_limit="36.46"/>
                    <measurement group_id="O7" value="25.0" lower_limit="13.19" upper_limit="40.34"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) IgG3 at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="39"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.2" lower_limit="28.35" upper_limit="58.97"/>
                    <measurement group_id="O2" value="42.1" lower_limit="26.31" upper_limit="59.18"/>
                    <measurement group_id="O3" value="7.1" lower_limit="1.5" upper_limit="19.48"/>
                    <measurement group_id="O4" value="51.2" lower_limit="35.13" upper_limit="67.12"/>
                    <measurement group_id="O5" value="35.9" lower_limit="21.2" upper_limit="52.82"/>
                    <measurement group_id="O6" value="15.4" lower_limit="5.86" upper_limit="30.53"/>
                    <measurement group_id="O7" value="43.2" lower_limit="27.1" upper_limit="60.51"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) IgG3 at Week 96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="25"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="22"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.2" lower_limit="4.08" upper_limit="26.2"/>
                    <measurement group_id="O2" value="8.3" lower_limit="1.75" upper_limit="22.47"/>
                    <measurement group_id="O3" value="4.0" lower_limit="0.1" upper_limit="20.35"/>
                    <measurement group_id="O4" value="4.5" lower_limit="0.12" upper_limit="22.84"/>
                    <measurement group_id="O5" value="13.6" lower_limit="2.91" upper_limit="34.91"/>
                    <measurement group_id="O6" value="8.3" lower_limit="1.03" upper_limit="27"/>
                    <measurement group_id="O7" value="16.7" lower_limit="4.74" upper_limit="37.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) IgG4 at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="45"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.55"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.87"/>
                    <measurement group_id="O4" value="4.4" lower_limit="0.54" upper_limit="15.15"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="8.04"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) IgG4 at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="38"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" lower_limit="0.06" upper_limit="12.02"/>
                    <measurement group_id="O2" value="2.6" lower_limit="0.07" upper_limit="13.81"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O4" value="7.3" lower_limit="1.54" upper_limit="19.92"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="9.03"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="5.3" lower_limit="0.64" upper_limit="17.75"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Responders for Env ELISA Including Consensus C and Mos1 Antigens</title>
        <description>The response was defined as post-baseline value &gt;LLOQ if baseline &lt;LLOQ or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=LLOQ. The LLOQ for this assay is a 50 percent (%) inhibitory concentration (IC50) of 20 (fold-dilution). The lower limits of quantification (LLOQs) for this assay were 625 and 78.125 EU/mL for Clade C (Con C) and Mos1 respectively. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
        <time_frame>Week 28, 52 and 96</time_frame>
        <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Responders for Env ELISA Including Consensus C and Mos1 Antigens</title>
          <description>The response was defined as post-baseline value &gt;LLOQ if baseline &lt;LLOQ or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=LLOQ. The LLOQ for this assay is a 50 percent (%) inhibitory concentration (IC50) of 20 (fold-dilution). The lower limits of quantification (LLOQs) for this assay were 625 and 78.125 EU/mL for Clade C (Con C) and Mos1 respectively. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
          <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
          <units>percentage of responders</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="49"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="44"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="42"/>
                <count group_id="O7" value="44"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Consensus C (Con C) at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100" lower_limit="92.45" upper_limit="100"/>
                    <measurement group_id="O2" value="100.0" lower_limit="91.4" upper_limit="100"/>
                    <measurement group_id="O3" value="100.0" lower_limit="92.29" upper_limit="100"/>
                    <measurement group_id="O4" value="95.5" lower_limit="84.53" upper_limit="99.44"/>
                    <measurement group_id="O5" value="100.0" lower_limit="91.78" upper_limit="100"/>
                    <measurement group_id="O6" value="100.0" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O7" value="97.7" lower_limit="87.98" upper_limit="99.94"/>
                    <measurement group_id="O8" value="6.5" lower_limit="1.37" upper_limit="17.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Consensus C (Con C) at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="38"/>
                    <count group_id="O8" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="92.13" upper_limit="100"/>
                    <measurement group_id="O2" value="100.0" lower_limit="91.19" upper_limit="100"/>
                    <measurement group_id="O3" value="100.0" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O4" value="95.1" lower_limit="83.47" upper_limit="99.4"/>
                    <measurement group_id="O5" value="100.0" lower_limit="91.19" upper_limit="100"/>
                    <measurement group_id="O6" value="100.0" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O7" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.06" upper_limit="12.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mos1 at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="92.29" upper_limit="100"/>
                    <measurement group_id="O2" value="100.0" lower_limit="91.19" upper_limit="100"/>
                    <measurement group_id="O3" value="100.0" lower_limit="92.29" upper_limit="100"/>
                    <measurement group_id="O4" value="97.7" lower_limit="87.71" upper_limit="99.94"/>
                    <measurement group_id="O5" value="100.0" lower_limit="91.78" upper_limit="100"/>
                    <measurement group_id="O6" value="100.0" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O7" value="97.7" lower_limit="87.98" upper_limit="99.94"/>
                    <measurement group_id="O8" value="4.3" lower_limit="0.53" upper_limit="14.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mos1 at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="36"/>
                    <count group_id="O8" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="91.96" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="91.19" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="91.4" upper_limit="100.0"/>
                    <measurement group_id="O4" value="97.5" lower_limit="86.84" upper_limit="99.94"/>
                    <measurement group_id="O5" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="91.59" upper_limit="100.0"/>
                    <measurement group_id="O7" value="100.0" lower_limit="90.26" upper_limit="100"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mos1 at Week 96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="35"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="91.59" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="91.59" upper_limit="100.0"/>
                    <measurement group_id="O4" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="91.59" upper_limit="100"/>
                    <measurement group_id="O7" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Responders for Env Antibody-dependent Cellular Phagocytosis (ADCP) gp Antibody</title>
        <description>The functionality of vaccine-induced antibody responses was investigated by the determination of ADCP. The response was defined as post-baseline value &gt; limit of detection (LOD) if baseline &lt;LOD or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=LOD. The lower limits of detection (LODs) for this assay were 5.16, 6.43, 6.49, 4.32 and 4.28 (phagocytic score) for Clade A (92UG037.1), Clade B (1990a), Clade C (Con C), Clade C (C97ZA.012), and Mos1, respectively. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category of Clade A, B, C and Mos 1.</description>
        <time_frame>Week 16, 26, 28, 52, 78, and 96</time_frame>
        <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Responders for Env Antibody-dependent Cellular Phagocytosis (ADCP) gp Antibody</title>
          <description>The functionality of vaccine-induced antibody responses was investigated by the determination of ADCP. The response was defined as post-baseline value &gt; limit of detection (LOD) if baseline &lt;LOD or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=LOD. The lower limits of detection (LODs) for this assay were 5.16, 6.43, 6.49, 4.32 and 4.28 (phagocytic score) for Clade A (92UG037.1), Clade B (1990a), Clade C (Con C), Clade C (C97ZA.012), and Mos1, respectively. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category of Clade A, B, C and Mos 1.</description>
          <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
          <units>percentage of responders</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="42"/>
                <count group_id="O6" value="42"/>
                <count group_id="O7" value="44"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Clade A (92UG037.1) at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="9"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0" lower_limit="2.52" upper_limit="55.61"/>
                    <measurement group_id="O2" value="20.0" lower_limit="2.52" upper_limit="55.61"/>
                    <measurement group_id="O3" value="10.0" lower_limit="0.25" upper_limit="44.5"/>
                    <measurement group_id="O4" value="66.7" lower_limit="29.93" upper_limit="92.51"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="36.94"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="45.93"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="33.63"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="36.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (92UG037.1) at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.2" lower_limit="22.67" upper_limit="51.48"/>
                    <measurement group_id="O2" value="29.3" lower_limit="16.13" upper_limit="45.54"/>
                    <measurement group_id="O3" value="6.5" lower_limit="1.37" upper_limit="17.9"/>
                    <measurement group_id="O4" value="46.7" lower_limit="31.66" upper_limit="62.13"/>
                    <measurement group_id="O5" value="21.4" lower_limit="10.3" upper_limit="36.81"/>
                    <measurement group_id="O6" value="22.5" lower_limit="10.84" upper_limit="38.45"/>
                    <measurement group_id="O7" value="9.1" lower_limit="2.53" upper_limit="21.67"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (1990a) at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="9"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="18.71" upper_limit="81.29"/>
                    <measurement group_id="O2" value="50.0" lower_limit="18.71" upper_limit="81.29"/>
                    <measurement group_id="O3" value="30.0" lower_limit="6.67" upper_limit="65.25"/>
                    <measurement group_id="O4" value="66.7" lower_limit="29.93" upper_limit="92.51"/>
                    <measurement group_id="O5" value="37.5" lower_limit="8.52" upper_limit="75.51"/>
                    <measurement group_id="O6" value="16.7" lower_limit="0.42" upper_limit="64.12"/>
                    <measurement group_id="O7" value="33.3" lower_limit="7.49" upper_limit="70.07"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="36.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (1990a) at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.7" lower_limit="64.34" upper_limit="89.3"/>
                    <measurement group_id="O2" value="53.7" lower_limit="37.42" upper_limit="69.34"/>
                    <measurement group_id="O3" value="37.0" lower_limit="23.21" upper_limit="52.45"/>
                    <measurement group_id="O4" value="71.1" lower_limit="55.69" upper_limit="83.63"/>
                    <measurement group_id="O5" value="61.9" lower_limit="45.64" upper_limit="76.43"/>
                    <measurement group_id="O6" value="72.5" lower_limit="56.11" upper_limit="85.4"/>
                    <measurement group_id="O7" value="36.4" lower_limit="2.41" upper_limit="52.23"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (Con C) at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="9"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.0" lower_limit="6.67" upper_limit="65.25"/>
                    <measurement group_id="O2" value="30.0" lower_limit="6.67" upper_limit="65.25"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="30.85"/>
                    <measurement group_id="O4" value="55.6" lower_limit="21.2" upper_limit="86.3"/>
                    <measurement group_id="O5" value="37.5" lower_limit="8.52" upper_limit="75.51"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="45.93"/>
                    <measurement group_id="O7" value="11.1" lower_limit="0.28" upper_limit="48.25"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="36.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (Con C) at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.3" lower_limit="40.12" upper_limit="69.83"/>
                    <measurement group_id="O2" value="39.0" lower_limit="24.2" upper_limit="55.5"/>
                    <measurement group_id="O3" value="41.3" lower_limit="27" upper_limit="56.77"/>
                    <measurement group_id="O4" value="53.3" lower_limit="37.87" upper_limit="68.34"/>
                    <measurement group_id="O5" value="45.2" lower_limit="29.85" upper_limit="61.33"/>
                    <measurement group_id="O6" value="47.5" lower_limit="31.51" upper_limit="63.87"/>
                    <measurement group_id="O7" value="43.2" lower_limit="28.35" upper_limit="58.97"/>
                    <measurement group_id="O8" value="8.7" lower_limit="2.42" upper_limit="20.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="9"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0" lower_limit="2.52" upper_limit="55.61"/>
                    <measurement group_id="O2" value="40.0" lower_limit="12.16" upper_limit="73.76"/>
                    <measurement group_id="O3" value="30.0" lower_limit="6.67" upper_limit="65.25"/>
                    <measurement group_id="O4" value="44.4" lower_limit="13.7" upper_limit="78.8"/>
                    <measurement group_id="O5" value="12.5" lower_limit="0.32" upper_limit="52.65"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="45.93"/>
                    <measurement group_id="O7" value="11.1" lower_limit="0.28" upper_limit="48.25"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="36.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) at Week 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.5" lower_limit="82.1" upper_limit="98.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.3" lower_limit="57.36" upper_limit="84.38"/>
                    <measurement group_id="O2" value="53.7" lower_limit="37.42" upper_limit="69.34"/>
                    <measurement group_id="O3" value="19.6" lower_limit="9.36" upper_limit="33.91"/>
                    <measurement group_id="O4" value="57.8" lower_limit="42.15" upper_limit="72.34"/>
                    <measurement group_id="O5" value="50.0" lower_limit="34.19" upper_limit="65.81"/>
                    <measurement group_id="O6" value="37.5" lower_limit="22.73" upper_limit="54.2"/>
                    <measurement group_id="O7" value="45.5" lower_limit="30.39" upper_limit="61.15"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="38"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.0" lower_limit="65.4" upper_limit="90.42"/>
                    <measurement group_id="O2" value="64.1" lower_limit="47.18" upper_limit="78.8"/>
                    <measurement group_id="O3" value="23.8" lower_limit="12.05" upper_limit="39.45"/>
                    <measurement group_id="O4" value="70.7" lower_limit="54.46" upper_limit="83.87"/>
                    <measurement group_id="O5" value="60.0" lower_limit="43.33" upper_limit="75.14"/>
                    <measurement group_id="O6" value="21.4" lower_limit="10.3" upper_limit="36.81"/>
                    <measurement group_id="O7" value="71.1" lower_limit="54.1" upper_limit="84.58"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) at Week 78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.5" lower_limit="16.76" upper_limit="45.2"/>
                    <measurement group_id="O2" value="15.4" lower_limit="5.86" upper_limit="30.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (C97ZA.012) at Week 96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="42"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="25"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="24"/>
                    <count group_id="O6" value="25"/>
                    <count group_id="O7" value="24"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.5" lower_limit="2.66" upper_limit="22.62"/>
                    <measurement group_id="O2" value="10.5" lower_limit="2.94" upper_limit="24.8"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="13.72"/>
                    <measurement group_id="O4" value="18.2" lower_limit="5.19" upper_limit="40.28"/>
                    <measurement group_id="O5" value="4.2" lower_limit="0.11" upper_limit="21.12"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="13.72"/>
                    <measurement group_id="O7" value="12.5" lower_limit="2.66" upper_limit="32.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mos1 at Week 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                    <count group_id="O2" value="10"/>
                    <count group_id="O3" value="10"/>
                    <count group_id="O4" value="9"/>
                    <count group_id="O5" value="8"/>
                    <count group_id="O6" value="6"/>
                    <count group_id="O7" value="9"/>
                    <count group_id="O8" value="8"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.0" lower_limit="55.5" upper_limit="99.75"/>
                    <measurement group_id="O2" value="90.0" lower_limit="55.5" upper_limit="99.75"/>
                    <measurement group_id="O3" value="70.0" lower_limit="34.75" upper_limit="93.33"/>
                    <measurement group_id="O4" value="77.8" lower_limit="39.99" upper_limit="97.19"/>
                    <measurement group_id="O5" value="100.0" lower_limit="63.06" upper_limit="100.0"/>
                    <measurement group_id="O6" value="83.3" lower_limit="35.88" upper_limit="99.58"/>
                    <measurement group_id="O7" value="88.9" lower_limit="51.75" upper_limit="99.72"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="36.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mos1 at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7" lower_limit="85.46" upper_limit="99.48"/>
                    <measurement group_id="O2" value="87.8" lower_limit="73.8" upper_limit="95.92"/>
                    <measurement group_id="O3" value="84.8" lower_limit="71.13" upper_limit="93.66"/>
                    <measurement group_id="O4" value="93.3" lower_limit="81.73" upper_limit="98.6"/>
                    <measurement group_id="O5" value="92.9" lower_limit="80.52" upper_limit="98.5"/>
                    <measurement group_id="O6" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O7" value="86.4" lower_limit="72.65" upper_limit="94.83"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Responders for Human Immunodeficiency Virus Neutralizing Antibody (HIV nAb)</title>
        <description>The functionality of vaccine-induced antibody responses was investigated by the determination of nAb activity in a virus neutralization assay (VNA) using TZM-bl cells and Env-pseudotyped viruses. The response was defined as post-baseline value &gt;LLOQ. The LLOQ for this assay is an inhibitory concentration (IC50) of 20 (fold-dilution). Data reported for the responses against Tier 1 HIV strain Clade C (MW965.26) was reported. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
        <time_frame>Week 28 and 52</time_frame>
        <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Responders for Human Immunodeficiency Virus Neutralizing Antibody (HIV nAb)</title>
          <description>The functionality of vaccine-induced antibody responses was investigated by the determination of nAb activity in a virus neutralization assay (VNA) using TZM-bl cells and Env-pseudotyped viruses. The response was defined as post-baseline value &gt;LLOQ. The LLOQ for this assay is an inhibitory concentration (IC50) of 20 (fold-dilution). Data reported for the responses against Tier 1 HIV strain Clade C (MW965.26) was reported. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
          <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
          <units>percentage of responders</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="41"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="45"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="42"/>
                <count group_id="O7" value="44"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Clade C (MW965.26) Tier 1 at Week 28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="41"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="45"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="44"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.2" lower_limit="39.17" upper_limit="68.63"/>
                    <measurement group_id="O2" value="41.5" lower_limit="26.32" upper_limit="57.89"/>
                    <measurement group_id="O3" value="21.7" lower_limit="10.95" upper_limit="36.36"/>
                    <measurement group_id="O4" value="51.1" lower_limit="35.77" upper_limit="66.3"/>
                    <measurement group_id="O5" value="43.2" lower_limit="28.35" upper_limit="58.97"/>
                    <measurement group_id="O6" value="36.6" lower_limit="22.12" upper_limit="53.06"/>
                    <measurement group_id="O7" value="29.5" lower_limit="16.76" upper_limit="45.2"/>
                    <measurement group_id="O8" value="2.2" lower_limit="0.06" upper_limit="11.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (MW965.26) Tier 1 at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="41"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="42"/>
                    <count group_id="O7" value="38"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.6" lower_limit="60.46" upper_limit="87.12"/>
                    <measurement group_id="O2" value="65.8" lower_limit="48.65" upper_limit="80.37"/>
                    <measurement group_id="O3" value="11.9" lower_limit="3.98" upper_limit="25.63"/>
                    <measurement group_id="O4" value="73.2" lower_limit="57.06" upper_limit="85.78"/>
                    <measurement group_id="O5" value="52.5" lower_limit="36.13" upper_limit="68.49"/>
                    <measurement group_id="O6" value="45.2" lower_limit="29.85" upper_limit="61.33"/>
                    <measurement group_id="O7" value="68.4" lower_limit="51.35" upper_limit="82.5"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.06" upper_limit="12.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Responders for Binding Antibody Multiplex Assay (BAMA) IgG1-IgG4 and IgA and IgG-t Breadth Antibody</title>
        <description>The human immunodeficiency virus (HIV)-1 BAMA employs flow-cytometric-based technology that also utilizes antibody and antigen interactions to test for the presence of specific antibodies in an unknown sample with the added advantage of multiplexing the antigens of interest. Positive and negative control standards were run with each assay to ensure specificity. The positivity threshold was determined per antigen based on the plus (+) 3 standard deviation (SD) on the non-specific background. Sample values had to be greater than or equal to this value and had to be 3-fold over the baseline values with a minimum median fluorescent intensities (MFI) value of 100. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
        <time_frame>Week 16, 28, 52, 78, and 96</time_frame>
        <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Responders for Binding Antibody Multiplex Assay (BAMA) IgG1-IgG4 and IgA and IgG-t Breadth Antibody</title>
          <description>The human immunodeficiency virus (HIV)-1 BAMA employs flow-cytometric-based technology that also utilizes antibody and antigen interactions to test for the presence of specific antibodies in an unknown sample with the added advantage of multiplexing the antigens of interest. Positive and negative control standards were run with each assay to ensure specificity. The positivity threshold was determined per antigen based on the plus (+) 3 standard deviation (SD) on the non-specific background. Sample values had to be greater than or equal to this value and had to be 3-fold over the baseline values with a minimum median fluorescent intensities (MFI) value of 100. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
          <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
          <units>percentage of responders</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="46"/>
                <count group_id="O4" value="44"/>
                <count group_id="O5" value="44"/>
                <count group_id="O6" value="44"/>
                <count group_id="O7" value="43"/>
                <count group_id="O8" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>HIV ENV Con S gp140 CFI(Clade M)IgG1 Ab Week(W)16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.6" lower_limit="61.97" upper_limit="87.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG1 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="41"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.8" lower_limit="85.75" upper_limit="99.49"/>
                    <measurement group_id="O2" value="94.6" lower_limit="81.81" upper_limit="99.34"/>
                    <measurement group_id="O3" value="76.1" lower_limit="61.23" upper_limit="87.41"/>
                    <measurement group_id="O4" value="90.9" lower_limit="78.33" upper_limit="97.47"/>
                    <measurement group_id="O5" value="97.6" lower_limit="87.14" upper_limit="99.94"/>
                    <measurement group_id="O6" value="95.1" lower_limit="83.47" upper_limit="99.4"/>
                    <measurement group_id="O7" value="88.4" lower_limit="74.92" upper_limit="96.11"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG1 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="36"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.6" lower_limit="84.85" upper_limit="99.46"/>
                    <measurement group_id="O2" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O3" value="61.9" lower_limit="45.64" upper_limit="76.43"/>
                    <measurement group_id="O4" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O5" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O6" value="80.5" lower_limit="65.13" upper_limit="91.18"/>
                    <measurement group_id="O7" value="94.4" lower_limit="81.34" upper_limit="99.32"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG1 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.9" lower_limit="6.2" upper_limit="28.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG1 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="41"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.4" lower_limit="45.27" upper_limit="74.23"/>
                    <measurement group_id="O2" value="40.5" lower_limit="24.75" upper_limit="57.9"/>
                    <measurement group_id="O3" value="15.2" lower_limit="6.34" upper_limit="28.87"/>
                    <measurement group_id="O4" value="59.1" lower_limit="43.25" upper_limit="73.66"/>
                    <measurement group_id="O5" value="39.0" lower_limit="24.2" upper_limit="55.5"/>
                    <measurement group_id="O6" value="39.0" lower_limit="24.2" upper_limit="55.5"/>
                    <measurement group_id="O7" value="23.3" lower_limit="11.76" upper_limit="38.63"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG1 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="36"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.0" lower_limit="44.33" upper_limit="74.3"/>
                    <measurement group_id="O2" value="44.1" lower_limit="27.19" upper_limit="62.11"/>
                    <measurement group_id="O3" value="11.9" lower_limit="3.98" upper_limit="25.63"/>
                    <measurement group_id="O4" value="62.5" lower_limit="45.8" upper_limit="77.27"/>
                    <measurement group_id="O5" value="35.1" lower_limit="20.21" upper_limit="52.54"/>
                    <measurement group_id="O6" value="19.5" lower_limit="8.82" upper_limit="34.87"/>
                    <measurement group_id="O7" value="22.2" lower_limit="10.12" upper_limit="39.15"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG1 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.6" lower_limit="44.27" upper_limit="73.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG1 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="41"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.8" lower_limit="85.75" upper_limit="99.49"/>
                    <measurement group_id="O2" value="94.6" lower_limit="81.81" upper_limit="99.34"/>
                    <measurement group_id="O3" value="78.3" lower_limit="63.64" upper_limit="89.05"/>
                    <measurement group_id="O4" value="90.9" lower_limit="78.33" upper_limit="97.47"/>
                    <measurement group_id="O5" value="97.6" lower_limit="87.14" upper_limit="99.94"/>
                    <measurement group_id="O6" value="82.9" lower_limit="67.94" upper_limit="92.85"/>
                    <measurement group_id="O7" value="95.3" lower_limit="84.19" upper_limit="99.43"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG1 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="36"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.6" lower_limit="84.85" upper_limit="99.46"/>
                    <measurement group_id="O2" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O3" value="61.9" lower_limit="45.64" upper_limit="76.43"/>
                    <measurement group_id="O4" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O5" value="97.3" lower_limit="85.84" upper_limit="99.93"/>
                    <measurement group_id="O6" value="68.3" lower_limit="51.91" upper_limit="81.92"/>
                    <measurement group_id="O7" value="97.2" lower_limit="85.47" upper_limit="99.93"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG1 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.4" lower_limit="26.37" upper_limit="55.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG1 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="41"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.4" lower_limit="72.24" upper_limit="93.93"/>
                    <measurement group_id="O2" value="70.3" lower_limit="53.02" upper_limit="84.13"/>
                    <measurement group_id="O3" value="56.5" lower_limit="41.11" upper_limit="71.07"/>
                    <measurement group_id="O4" value="79.5" lower_limit="64.7" upper_limit="90.2"/>
                    <measurement group_id="O5" value="87.8" lower_limit="73.8" upper_limit="95.92"/>
                    <measurement group_id="O6" value="70.7" lower_limit="54.46" upper_limit="83.87"/>
                    <measurement group_id="O7" value="72.1" lower_limit="56.33" upper_limit="84.67"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG1 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="36"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.0" lower_limit="65.4" upper_limit="90.42"/>
                    <measurement group_id="O2" value="79.4" lower_limit="62.1" upper_limit="91.3"/>
                    <measurement group_id="O3" value="35.7" lower_limit="21.55" upper_limit="51.97"/>
                    <measurement group_id="O4" value="82.5" lower_limit="67.22" upper_limit="92.66"/>
                    <measurement group_id="O5" value="83.8" lower_limit="67.99" upper_limit="93.81"/>
                    <measurement group_id="O6" value="46.3" lower_limit="30.66" upper_limit="62.58"/>
                    <measurement group_id="O7" value="83.3" lower_limit="67.19" upper_limit="93.63"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG1 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.5" lower_limit="59.65" upper_limit="86.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG1 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="41"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.8" lower_limit="82.8" upper_limit="98.69"/>
                    <measurement group_id="O2" value="94.6" lower_limit="81.81" upper_limit="99.34"/>
                    <measurement group_id="O3" value="76.1" lower_limit="61.23" upper_limit="87.41"/>
                    <measurement group_id="O4" value="90.9" lower_limit="78.33" upper_limit="97.47"/>
                    <measurement group_id="O5" value="100.0" lower_limit="91.4" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="91.4" upper_limit="100.0"/>
                    <measurement group_id="O7" value="86.0" lower_limit="72.07" upper_limit="94.7"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG1 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="36"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.6" lower_limit="84.85" upper_limit="99.46"/>
                    <measurement group_id="O2" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O3" value="76.2" lower_limit="60.55" upper_limit="87.95"/>
                    <measurement group_id="O4" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O5" value="97.3" lower_limit="85.84" upper_limit="99.93"/>
                    <measurement group_id="O6" value="90.2" lower_limit="76.87" upper_limit="97.28"/>
                    <measurement group_id="O7" value="94.4" lower_limit="81.34" upper_limit="99.32"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG1 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.4" lower_limit="1.34" upper_limit="17.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG1 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="41"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.7" lower_limit="7.48" upper_limit="30.22"/>
                    <measurement group_id="O2" value="10.8" lower_limit="3.03" upper_limit="25.42"/>
                    <measurement group_id="O3" value="2.2" lower_limit="0.06" upper_limit="11.53"/>
                    <measurement group_id="O4" value="18.2" lower_limit="8.19" upper_limit="32.71"/>
                    <measurement group_id="O5" value="19.5" lower_limit="8.82" upper_limit="34.87"/>
                    <measurement group_id="O6" value="4.9" lower_limit="0.6" upper_limit="16.53"/>
                    <measurement group_id="O7" value="7.0" lower_limit="1.46" upper_limit="19.06"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG1 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="36"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.0" lower_limit="9.58" upper_limit="34.6"/>
                    <measurement group_id="O2" value="8.8" lower_limit="1.86" upper_limit="23.68"/>
                    <measurement group_id="O3" value="4.8" lower_limit="0.58" upper_limit="16.16"/>
                    <measurement group_id="O4" value="25.0" lower_limit="12.69" upper_limit="41.2"/>
                    <measurement group_id="O5" value="13.5" lower_limit="4.54" upper_limit="28.77"/>
                    <measurement group_id="O6" value="9.8" lower_limit="2.72" upper_limit="23.13"/>
                    <measurement group_id="O7" value="13.9" lower_limit="4.67" upper_limit="29.5"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG1 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.9" lower_limit="6.2" upper_limit="28.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG1 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="41"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.2" lower_limit="16.95" upper_limit="44.06"/>
                    <measurement group_id="O2" value="27.0" lower_limit="13.79" upper_limit="44.12"/>
                    <measurement group_id="O3" value="10.9" lower_limit="3.62" upper_limit="23.57"/>
                    <measurement group_id="O4" value="20.5" lower_limit="9.8" upper_limit="35.3"/>
                    <measurement group_id="O5" value="22.0" lower_limit="10.56" upper_limit="37.61"/>
                    <measurement group_id="O6" value="7.3" lower_limit="1.54" upper_limit="19.92"/>
                    <measurement group_id="O7" value="7.0" lower_limit="1.46" upper_limit="19.06"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG1 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="36"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.3" lower_limit="5.05" upper_limit="26.79"/>
                    <measurement group_id="O2" value="14.7" lower_limit="4.95" upper_limit="31.06"/>
                    <measurement group_id="O3" value="9.5" lower_limit="2.66" upper_limit="22.62"/>
                    <measurement group_id="O4" value="22.5" lower_limit="10.84" upper_limit="38.45"/>
                    <measurement group_id="O5" value="13.5" lower_limit="4.54" upper_limit="28.77"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="13.9" lower_limit="4.67" upper_limit="29.5"/>
                    <measurement group_id="O8" value="2.4" lower_limit="0.06" upper_limit="12.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG2 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG2 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.05" upper_limit="11.07"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.71"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG2 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" lower_limit="0.06" upper_limit="11.77"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG2 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG2 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.71"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG2 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.87"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG2 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG2 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.05" upper_limit="11.07"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.71"/>
                    <measurement group_id="O4" value="2.3" lower_limit="0.06" upper_limit="12.29"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.06" upper_limit="12.57"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG2 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.87"/>
                    <measurement group_id="O2" value="2.7" lower_limit="0.07" upper_limit="14.16"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O4" value="5.0" lower_limit="0.61" upper_limit="16.92"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG2 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.05" upper_limit="11.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG2 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.05" upper_limit="11.07"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.71"/>
                    <measurement group_id="O4" value="2.3" lower_limit="0.06" upper_limit="12.29"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG2 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.87"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG2 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.05" upper_limit="11.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG2 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="41"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.05" upper_limit="11.07"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.71"/>
                    <measurement group_id="O4" value="2.3" lower_limit="0.06" upper_limit="12.29"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG2 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" lower_limit="0.06" upper_limit="11.77"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O4" value="2.5" lower_limit="0.06" upper_limit="13.16"/>
                    <measurement group_id="O5" value="2.7" lower_limit="0.07" upper_limit="14.16"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG2 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG2 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.71"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG2 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.87"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG2 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG2 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="42"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.06" upper_limit="13.16"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.71"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O5" value="2.4" lower_limit="0.06" upper_limit="12.57"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG2 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="37"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.87"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O4" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="9.49"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG3 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.7" lower_limit="46.38" upper_limit="75.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG3 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.0" lower_limit="60.4" upper_limit="86.36"/>
                    <measurement group_id="O2" value="47.5" lower_limit="31.51" upper_limit="63.87"/>
                    <measurement group_id="O3" value="34.8" lower_limit="21.35" upper_limit="50.25"/>
                    <measurement group_id="O4" value="76.7" lower_limit="61.37" upper_limit="88.24"/>
                    <measurement group_id="O5" value="79.1" lower_limit="63.96" upper_limit="89.96"/>
                    <measurement group_id="O6" value="58.5" lower_limit="42.11" upper_limit="73.68"/>
                    <measurement group_id="O7" value="67.4" lower_limit="51.46" upper_limit="80.92"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG3 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.7" lower_limit="61.37" upper_limit="88.24"/>
                    <measurement group_id="O2" value="59.5" lower_limit="42.1" upper_limit="75.25"/>
                    <measurement group_id="O3" value="56.1" lower_limit="39.75" upper_limit="71.53"/>
                    <measurement group_id="O4" value="78.9" lower_limit="62.68" upper_limit="90.45"/>
                    <measurement group_id="O5" value="82.1" lower_limit="66.47" upper_limit="92.46"/>
                    <measurement group_id="O6" value="48.8" lower_limit="32.88" upper_limit="64.87"/>
                    <measurement group_id="O7" value="81.1" lower_limit="64.84" upper_limit="92.04"/>
                    <measurement group_id="O8" value="7.7" lower_limit="1.62" upper_limit="20.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG3 Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.5" lower_limit="37.65" upper_limit="68.82"/>
                    <measurement group_id="O2" value="28.9" lower_limit="15.42" upper_limit="45.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG3 Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.8" lower_limit="32.88" upper_limit="64.87"/>
                    <measurement group_id="O2" value="34.3" lower_limit="19.13" upper_limit="52.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG3 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.9" lower_limit="19.09" upper_limit="47.12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG3 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.3" lower_limit="18.66" upper_limit="46.25"/>
                    <measurement group_id="O2" value="22.5" lower_limit="10.84" upper_limit="38.45"/>
                    <measurement group_id="O3" value="10.9" lower_limit="3.62" upper_limit="23.57"/>
                    <measurement group_id="O4" value="32.6" lower_limit="19.08" upper_limit="48.54"/>
                    <measurement group_id="O5" value="23.3" lower_limit="11.76" upper_limit="38.63"/>
                    <measurement group_id="O6" value="22.0" lower_limit="10.56" upper_limit="37.61"/>
                    <measurement group_id="O7" value="11.6" lower_limit="3.89" upper_limit="25.08"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG3 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.8" lower_limit="33.31" upper_limit="64.54"/>
                    <measurement group_id="O2" value="27.0" lower_limit="13.79" upper_limit="44.12"/>
                    <measurement group_id="O3" value="17.1" lower_limit="7.15" upper_limit="32.06"/>
                    <measurement group_id="O4" value="47.4" lower_limit="30.98" upper_limit="64.18"/>
                    <measurement group_id="O5" value="46.2" lower_limit="30.09" upper_limit="62.82"/>
                    <measurement group_id="O6" value="31.7" lower_limit="18.08" upper_limit="48.09"/>
                    <measurement group_id="O7" value="24.3" lower_limit="11.77" upper_limit="41.2"/>
                    <measurement group_id="O8" value="2.6" lower_limit="0.06" upper_limit="13.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG3 Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.0" lower_limit="5.3" upper_limit="27.93"/>
                    <measurement group_id="O2" value="7.9" lower_limit="1.66" upper_limit="21.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG3 Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.1" lower_limit="7.15" upper_limit="32.06"/>
                    <measurement group_id="O2" value="8.6" lower_limit="1.8" upper_limit="23.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG3 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.5" lower_limit="13.94" upper_limit="40.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG3 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.1" lower_limit="37.19" upper_limit="66.71"/>
                    <measurement group_id="O2" value="45.0" lower_limit="29.26" upper_limit="61.51"/>
                    <measurement group_id="O3" value="13.0" lower_limit="4.94" upper_limit="26.26"/>
                    <measurement group_id="O4" value="55.8" lower_limit="39.88" upper_limit="70.92"/>
                    <measurement group_id="O5" value="58.1" lower_limit="42.13" upper_limit="72.99"/>
                    <measurement group_id="O6" value="26.8" lower_limit="14.22" upper_limit="42.94"/>
                    <measurement group_id="O7" value="46.5" lower_limit="31.18" upper_limit="62.35"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>43HIV ENV gp41 IgG3 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="41"/>
                    <count group_id="O8" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.4" lower_limit="51.46" upper_limit="80.92"/>
                    <measurement group_id="O2" value="54.1" lower_limit="36.92" upper_limit="70.51"/>
                    <measurement group_id="O3" value="14.6" lower_limit="5.57" upper_limit="29.17"/>
                    <measurement group_id="O4" value="73.7" lower_limit="56.9" upper_limit="86.6"/>
                    <measurement group_id="O5" value="79.5" lower_limit="63.54" upper_limit="90.7"/>
                    <measurement group_id="O6" value="26.8" lower_limit="14.22" upper_limit="42.94"/>
                    <measurement group_id="O7" value="67.6" lower_limit="50.21" upper_limit="81.99"/>
                    <measurement group_id="O8" value="7.7" lower_limit="1.62" upper_limit="20.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG3 Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.9" lower_limit="21.01" upper_limit="50.93"/>
                    <measurement group_id="O2" value="23.7" lower_limit="11.44" upper_limit="40.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG3 Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.7" lower_limit="18.08" upper_limit="48.09"/>
                    <measurement group_id="O2" value="22.9" lower_limit="10.42" upper_limit="40.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG3 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.1" lower_limit="52.88" upper_limit="80.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG3 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" lower_limit="51.59" upper_limit="79.6"/>
                    <measurement group_id="O2" value="50.0" lower_limit="33.8" upper_limit="66.2"/>
                    <measurement group_id="O3" value="39.1" lower_limit="25.09" upper_limit="54.63"/>
                    <measurement group_id="O4" value="65.1" lower_limit="49.07" upper_limit="78.99"/>
                    <measurement group_id="O5" value="65.1" lower_limit="49.07" upper_limit="78.99"/>
                    <measurement group_id="O6" value="58.5" lower_limit="42.11" upper_limit="73.68"/>
                    <measurement group_id="O7" value="53.5" lower_limit="37.65" upper_limit="68.82"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG3 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.7" lower_limit="61.37" upper_limit="88.24"/>
                    <measurement group_id="O2" value="67.6" lower_limit="50.21" upper_limit="81.99"/>
                    <measurement group_id="O3" value="51.2" lower_limit="35.13" upper_limit="67.12"/>
                    <measurement group_id="O4" value="78.9" lower_limit="62.68" upper_limit="90.45"/>
                    <measurement group_id="O5" value="82.1" lower_limit="66.47" upper_limit="92.46"/>
                    <measurement group_id="O6" value="58.5" lower_limit="42.11" upper_limit="73.68"/>
                    <measurement group_id="O7" value="75.7" lower_limit="58.8" upper_limit="88.23"/>
                    <measurement group_id="O8" value="2.6" lower_limit="0.06" upper_limit="13.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG3 Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.5" lower_limit="37.65" upper_limit="68.82"/>
                    <measurement group_id="O2" value="39.5" lower_limit="24.04" upper_limit="56.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG3 Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.8" lower_limit="32.88" upper_limit="64.87"/>
                    <measurement group_id="O2" value="37.1" lower_limit="21.47" upper_limit="55.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG3 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.5" lower_limit="59.65" upper_limit="86.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG3 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.3" lower_limit="69.78" upper_limit="92.52"/>
                    <measurement group_id="O2" value="60.0" lower_limit="43.33" upper_limit="75.14"/>
                    <measurement group_id="O3" value="67.4" lower_limit="51.98" upper_limit="80.47"/>
                    <measurement group_id="O4" value="86.0" lower_limit="72.07" upper_limit="94.7"/>
                    <measurement group_id="O5" value="86.0" lower_limit="72.07" upper_limit="94.7"/>
                    <measurement group_id="O6" value="75.6" lower_limit="59.7" upper_limit="87.64"/>
                    <measurement group_id="O7" value="76.7" lower_limit="61.37" upper_limit="88.24"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG3 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.4" lower_limit="66.6" upper_limit="91.61"/>
                    <measurement group_id="O2" value="70.3" lower_limit="53.02" upper_limit="84.13"/>
                    <measurement group_id="O3" value="65.9" lower_limit="49.41" upper_limit="79.92"/>
                    <measurement group_id="O4" value="86.8" lower_limit="71.91" upper_limit="95.59"/>
                    <measurement group_id="O5" value="87.2" lower_limit="72.57" upper_limit="95.7"/>
                    <measurement group_id="O6" value="61.0" lower_limit="44.5" upper_limit="75.8"/>
                    <measurement group_id="O7" value="83.8" lower_limit="67.99" upper_limit="93.81"/>
                    <measurement group_id="O8" value="2.6" lower_limit="0.06" upper_limit="13.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG3 Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.8" lower_limit="39.88" upper_limit="70.92"/>
                    <measurement group_id="O2" value="36.8" lower_limit="21.81" upper_limit="54.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG3 Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.3" lower_limit="30.66" upper_limit="62.58"/>
                    <measurement group_id="O2" value="31.4" lower_limit="16.85" upper_limit="49.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG3 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.8" lower_limit="4.83" upper_limit="25.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG3 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.8" lower_limit="8.95" upper_limit="32.63"/>
                    <measurement group_id="O2" value="12.5" lower_limit="4.19" upper_limit="26.8"/>
                    <measurement group_id="O3" value="6.5" lower_limit="1.37" upper_limit="17.9"/>
                    <measurement group_id="O4" value="23.3" lower_limit="11.76" upper_limit="38.63"/>
                    <measurement group_id="O5" value="16.3" lower_limit="6.81" upper_limit="30.7"/>
                    <measurement group_id="O6" value="14.6" lower_limit="5.57" upper_limit="29.17"/>
                    <measurement group_id="O7" value="16.3" lower_limit="6.81" upper_limit="30.7"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG3 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.6" lower_limit="13.52" upper_limit="41.17"/>
                    <measurement group_id="O2" value="10.8" lower_limit="3.03" upper_limit="25.42"/>
                    <measurement group_id="O3" value="9.8" lower_limit="2.72" upper_limit="23.13"/>
                    <measurement group_id="O4" value="28.9" lower_limit="15.42" upper_limit="45.9"/>
                    <measurement group_id="O5" value="15.4" lower_limit="5.86" upper_limit="30.53"/>
                    <measurement group_id="O6" value="9.8" lower_limit="2.72" upper_limit="23.13"/>
                    <measurement group_id="O7" value="16.2" lower_limit="6.19" upper_limit="32.01"/>
                    <measurement group_id="O8" value="2.6" lower_limit="0.06" upper_limit="13.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG3 Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.7" lower_limit="0.57" upper_limit="15.81"/>
                    <measurement group_id="O2" value="2.6" lower_limit="0.07" upper_limit="13.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG3 Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.8" lower_limit="2.72" upper_limit="23.13"/>
                    <measurement group_id="O2" value="8.6" lower_limit="1.8" upper_limit="23.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG3 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.9" lower_limit="6.2" upper_limit="28.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG3 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="45"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5" lower_limit="4.73" upper_limit="25.25"/>
                    <measurement group_id="O2" value="12.5" lower_limit="4.19" upper_limit="26.8"/>
                    <measurement group_id="O3" value="11.1" lower_limit="3.71" upper_limit="24.05"/>
                    <measurement group_id="O4" value="18.6" lower_limit="8.39" upper_limit="33.4"/>
                    <measurement group_id="O5" value="11.6" lower_limit="3.89" upper_limit="25.08"/>
                    <measurement group_id="O6" value="12.2" lower_limit="4.08" upper_limit="26.2"/>
                    <measurement group_id="O7" value="7.0" lower_limit="1.46" upper_limit="19.06"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG3 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="39"/>
                    <count group_id="O6" value="40"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="39"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.6" lower_limit="8.39" upper_limit="33.4"/>
                    <measurement group_id="O2" value="10.8" lower_limit="3.03" upper_limit="25.42"/>
                    <measurement group_id="O3" value="5.0" lower_limit="0.61" upper_limit="16.92"/>
                    <measurement group_id="O4" value="28.9" lower_limit="15.42" upper_limit="45.9"/>
                    <measurement group_id="O5" value="7.7" lower_limit="1.62" upper_limit="20.87"/>
                    <measurement group_id="O6" value="7.5" lower_limit="1.57" upper_limit="20.39"/>
                    <measurement group_id="O7" value="10.8" lower_limit="3.03" upper_limit="25.42"/>
                    <measurement group_id="O8" value="2.6" lower_limit="0.06" upper_limit="13.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG3 Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="43"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" lower_limit="0.06" upper_limit="12.29"/>
                    <measurement group_id="O2" value="2.6" lower_limit="0.07" upper_limit="13.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG3 Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" lower_limit="0.06" upper_limit="12.86"/>
                    <measurement group_id="O2" value="2.9" lower_limit="0.07" upper_limit="14.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG4 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" lower_limit="3.47" upper_limit="22.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG4 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5" lower_limit="4.73" upper_limit="25.25"/>
                    <measurement group_id="O2" value="10.0" lower_limit="2.79" upper_limit="23.66"/>
                    <measurement group_id="O3" value="13.0" lower_limit="4.94" upper_limit="26.26"/>
                    <measurement group_id="O4" value="9.3" lower_limit="2.59" upper_limit="22.14"/>
                    <measurement group_id="O5" value="9.1" lower_limit="2.53" upper_limit="21.67"/>
                    <measurement group_id="O6" value="7.3" lower_limit="1.54" upper_limit="19.92"/>
                    <measurement group_id="O7" value="16.3" lower_limit="6.81" upper_limit="30.7"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgG4 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.0" lower_limit="25.7" upper_limit="55.67"/>
                    <measurement group_id="O2" value="29.7" lower_limit="15.87" upper_limit="46.98"/>
                    <measurement group_id="O3" value="19.0" lower_limit="8.6" upper_limit="34.12"/>
                    <measurement group_id="O4" value="28.9" lower_limit="15.42" upper_limit="45.9"/>
                    <measurement group_id="O5" value="20.0" lower_limit="9.05" upper_limit="35.65"/>
                    <measurement group_id="O6" value="12.2" lower_limit="4.08" upper_limit="26.2"/>
                    <measurement group_id="O7" value="35.1" lower_limit="20.21" upper_limit="52.54"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG4 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG4 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.05" upper_limit="11.07"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.06" upper_limit="13.16"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.71"/>
                    <measurement group_id="O4" value="4.7" lower_limit="0.57" upper_limit="15.81"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="8.04"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="7.0" lower_limit="1.46" upper_limit="19.06"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgG4 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.6" lower_limit="6.49" upper_limit="29.46"/>
                    <measurement group_id="O2" value="10.8" lower_limit="3.03" upper_limit="25.42"/>
                    <measurement group_id="O3" value="2.4" lower_limit="0.06" upper_limit="12.57"/>
                    <measurement group_id="O4" value="18.4" lower_limit="7.74" upper_limit="34.33"/>
                    <measurement group_id="O5" value="5.0" lower_limit="0.61" upper_limit="16.92"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="8.1" lower_limit="1.7" upper_limit="21.91"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG4 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" lower_limit="3.47" upper_limit="22.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG4 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="20.4" upper_limit="48.41"/>
                    <measurement group_id="O2" value="15.0" lower_limit="5.71" upper_limit="29.84"/>
                    <measurement group_id="O3" value="13.0" lower_limit="4.94" upper_limit="26.26"/>
                    <measurement group_id="O4" value="25.6" lower_limit="13.52" upper_limit="41.17"/>
                    <measurement group_id="O5" value="20.5" lower_limit="9.8" upper_limit="35.3"/>
                    <measurement group_id="O6" value="7.3" lower_limit="1.54" upper_limit="19.92"/>
                    <measurement group_id="O7" value="34.9" lower_limit="21.01" upper_limit="50.93"/>
                    <measurement group_id="O8" value="2.2" lower_limit="0.06" upper_limit="11.77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgG4 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.7" lower_limit="51.05" upper_limit="80"/>
                    <measurement group_id="O2" value="56.8" lower_limit="39.49" upper_limit="72.9"/>
                    <measurement group_id="O3" value="16.7" lower_limit="6.97" upper_limit="31.36"/>
                    <measurement group_id="O4" value="52.6" lower_limit="35.82" upper_limit="69.02"/>
                    <measurement group_id="O5" value="45.0" lower_limit="29.26" upper_limit="61.51"/>
                    <measurement group_id="O6" value="7.3" lower_limit="1.54" upper_limit="19.92"/>
                    <measurement group_id="O7" value="62.2" lower_limit="44.76" upper_limit="77.54"/>
                    <measurement group_id="O8" value="7.3" lower_limit="1.54" upper_limit="19.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG4 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.4" lower_limit="3.47" upper_limit="22.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG4 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="44"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.6" lower_limit="6.07" upper_limit="27.76"/>
                    <measurement group_id="O2" value="7.5" lower_limit="1.57" upper_limit="20.39"/>
                    <measurement group_id="O3" value="6.5" lower_limit="1.37" upper_limit="17.9"/>
                    <measurement group_id="O4" value="9.3" lower_limit="2.59" upper_limit="22.14"/>
                    <measurement group_id="O5" value="6.8" lower_limit="1.43" upper_limit="18.66"/>
                    <measurement group_id="O6" value="9.8" lower_limit="2.72" upper_limit="23.13"/>
                    <measurement group_id="O7" value="14.0" lower_limit="5.3" upper_limit="27.93"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgG4 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.1" lower_limit="18.17" upper_limit="46.65"/>
                    <measurement group_id="O2" value="21.6" lower_limit="9.83" upper_limit="38.21"/>
                    <measurement group_id="O3" value="9.5" lower_limit="2.66" upper_limit="22.62"/>
                    <measurement group_id="O4" value="28.9" lower_limit="15.42" upper_limit="45.9"/>
                    <measurement group_id="O5" value="20.0" lower_limit="9.05" upper_limit="35.65"/>
                    <measurement group_id="O6" value="12.2" lower_limit="4.08" upper_limit="26.2"/>
                    <measurement group_id="O7" value="27.0" lower_limit="13.79" upper_limit="44.12"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG4 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.5" lower_limit="4.73" upper_limit="25.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG4 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.8" lower_limit="8.95" upper_limit="32.63"/>
                    <measurement group_id="O2" value="12.5" lower_limit="4.19" upper_limit="26.8"/>
                    <measurement group_id="O3" value="10.9" lower_limit="3.62" upper_limit="23.57"/>
                    <measurement group_id="O4" value="9.3" lower_limit="2.59" upper_limit="22.14"/>
                    <measurement group_id="O5" value="13.6" lower_limit="5.17" upper_limit="27.35"/>
                    <measurement group_id="O6" value="9.8" lower_limit="2.72" upper_limit="23.13"/>
                    <measurement group_id="O7" value="16.3" lower_limit="6.81" upper_limit="30.7"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C gp140 (Clade C) IgG4 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.7" lower_limit="31.66" upper_limit="62.13"/>
                    <measurement group_id="O2" value="35.1" lower_limit="20.21" upper_limit="52.54"/>
                    <measurement group_id="O3" value="16.7" lower_limit="6.97" upper_limit="31.36"/>
                    <measurement group_id="O4" value="28.9" lower_limit="15.42" upper_limit="45.9"/>
                    <measurement group_id="O5" value="40.0" lower_limit="24.86" upper_limit="56.67"/>
                    <measurement group_id="O6" value="22.0" lower_limit="10.56" upper_limit="37.61"/>
                    <measurement group_id="O7" value="37.8" lower_limit="22.46" upper_limit="55.24"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG4 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG4 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.1" lower_limit="0.05" upper_limit="11.07"/>
                    <measurement group_id="O2" value="2.5" lower_limit="0.06" upper_limit="13.16"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.71"/>
                    <measurement group_id="O4" value="4.7" lower_limit="0.57" upper_limit="15.81"/>
                    <measurement group_id="O5" value="2.3" lower_limit="0.06" upper_limit="12.02"/>
                    <measurement group_id="O6" value="2.4" lower_limit="0.06" upper_limit="12.86"/>
                    <measurement group_id="O7" value="2.3" lower_limit="0.06" upper_limit="12.29"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_V1V2 gp70 (Clade C) IgG4 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" lower_limit="0.06" upper_limit="11.77"/>
                    <measurement group_id="O2" value="5.4" lower_limit="0.66" upper_limit="18.19"/>
                    <measurement group_id="O3" value="4.8" lower_limit="0.58" upper_limit="16.16"/>
                    <measurement group_id="O4" value="2.6" lower_limit="0.07" upper_limit="13.81"/>
                    <measurement group_id="O5" value="2.5" lower_limit="0.06" upper_limit="13.16"/>
                    <measurement group_id="O6" value="2.4" lower_limit="0.06" upper_limit="12.86"/>
                    <measurement group_id="O7" value="5.4" lower_limit="0.66" upper_limit="18.19"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG4 Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG4 Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="40"/>
                    <count group_id="O3" value="46"/>
                    <count group_id="O4" value="43"/>
                    <count group_id="O5" value="44"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.4"/>
                    <measurement group_id="O2" value="0" lower_limit="0" upper_limit="8.81"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="7.71"/>
                    <measurement group_id="O4" value="2.3" lower_limit="0.06" upper_limit="12.29"/>
                    <measurement group_id="O5" value="0" lower_limit="0" upper_limit="8.04"/>
                    <measurement group_id="O6" value="0" lower_limit="0" upper_limit="8.6"/>
                    <measurement group_id="O7" value="0" lower_limit="0" upper_limit="8.22"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp70_B.CaseA_V1V2 (Clade B) IgG4 Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="37"/>
                    <count group_id="O3" value="42"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="40"/>
                    <count group_id="O6" value="41"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" lower_limit="0" upper_limit="7.87"/>
                    <measurement group_id="O2" value="2.7" lower_limit="0.07" upper_limit="14.16"/>
                    <measurement group_id="O3" value="0" lower_limit="0" upper_limit="8.41"/>
                    <measurement group_id="O4" value="5.3" lower_limit="0.64" upper_limit="17.75"/>
                    <measurement group_id="O5" value="2.5" lower_limit="0.06" upper_limit="13.16"/>
                    <measurement group_id="O6" value="2.4" lower_limit="0.06" upper_limit="12.86"/>
                    <measurement group_id="O7" value="2.7" lower_limit="0.07" upper_limit="14.16"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgA Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.0" lower_limit="43.33" upper_limit="75.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgA Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.9" lower_limit="60.67" upper_limit="88.87"/>
                    <measurement group_id="O2" value="87.1" lower_limit="70.17" upper_limit="96.37"/>
                    <measurement group_id="O3" value="77.8" lower_limit="60.85" upper_limit="89.88"/>
                    <measurement group_id="O4" value="82.9" lower_limit="66.35" upper_limit="93.44"/>
                    <measurement group_id="O5" value="85.3" lower_limit="68.94" upper_limit="95.05"/>
                    <measurement group_id="O6" value="78.9" lower_limit="62.68" upper_limit="90.45"/>
                    <measurement group_id="O7" value="83.8" lower_limit="67.99" upper_limit="93.81"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con S gp140 CFI (Clade M) IgA Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="31"/>
                    <count group_id="O4" value="26"/>
                    <count group_id="O5" value="26"/>
                    <count group_id="O6" value="32"/>
                    <count group_id="O7" value="29"/>
                    <count group_id="O8" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77.1" lower_limit="59.86" upper_limit="89.58"/>
                    <measurement group_id="O2" value="92.0" lower_limit="73.97" upper_limit="99.02"/>
                    <measurement group_id="O3" value="61.3" lower_limit="42.19" upper_limit="78.15"/>
                    <measurement group_id="O4" value="84.6" lower_limit="65.13" upper_limit="95.64"/>
                    <measurement group_id="O5" value="69.2" lower_limit="48.21" upper_limit="85.67"/>
                    <measurement group_id="O6" value="68.8" lower_limit="49.99" upper_limit="83.88"/>
                    <measurement group_id="O7" value="86.2" lower_limit="68.34" upper_limit="96.11"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="10.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgA Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.5" lower_limit="36.13" upper_limit="68.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgA Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.0" lower_limit="42.1" upper_limit="74.43"/>
                    <measurement group_id="O2" value="45.2" lower_limit="27.32" upper_limit="63.97"/>
                    <measurement group_id="O3" value="44.4" lower_limit="27.94" upper_limit="61.9"/>
                    <measurement group_id="O4" value="45.7" lower_limit="28.83" upper_limit="63.35"/>
                    <measurement group_id="O5" value="47.1" lower_limit="29.78" upper_limit="64.87"/>
                    <measurement group_id="O6" value="39.5" lower_limit="24.04" upper_limit="56.61"/>
                    <measurement group_id="O7" value="48.6" lower_limit="31.92" upper_limit="65.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV Con 6 gp120/B (Clade M) IgA Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="31"/>
                    <count group_id="O4" value="26"/>
                    <count group_id="O5" value="26"/>
                    <count group_id="O6" value="32"/>
                    <count group_id="O7" value="29"/>
                    <count group_id="O8" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.0" lower_limit="42.11" upper_limit="76.13"/>
                    <measurement group_id="O2" value="40.0" lower_limit="21.13" upper_limit="61.33"/>
                    <measurement group_id="O3" value="45.2" lower_limit="27.32" upper_limit="63.97"/>
                    <measurement group_id="O4" value="50.0" lower_limit="29.93" upper_limit="70.07"/>
                    <measurement group_id="O5" value="42.3" lower_limit="23.35" upper_limit="63.08"/>
                    <measurement group_id="O6" value="43.8" lower_limit="26.36" upper_limit="62.34"/>
                    <measurement group_id="O7" value="55.2" lower_limit="35.69" upper_limit="73.55"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="10.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgA Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.5" lower_limit="50.87" upper_limit="81.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgA Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.8" lower_limit="55.13" upper_limit="85"/>
                    <measurement group_id="O2" value="77.4" lower_limit="58.9" upper_limit="90.41"/>
                    <measurement group_id="O3" value="61.1" lower_limit="43.46" upper_limit="76.86"/>
                    <measurement group_id="O4" value="74.3" lower_limit="56.74" upper_limit="87.51"/>
                    <measurement group_id="O5" value="79.4" lower_limit="62.1" upper_limit="91.3"/>
                    <measurement group_id="O6" value="68.4" lower_limit="51.35" upper_limit="82.5"/>
                    <measurement group_id="O7" value="78.4" lower_limit="61.79" upper_limit="90.17"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 1086C_D7 gp120 (Clade C) IgA Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="31"/>
                    <count group_id="O4" value="26"/>
                    <count group_id="O5" value="26"/>
                    <count group_id="O6" value="32"/>
                    <count group_id="O7" value="29"/>
                    <count group_id="O8" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.3" lower_limit="56.74" upper_limit="87.51"/>
                    <measurement group_id="O2" value="68.0" lower_limit="46.5" upper_limit="85.05"/>
                    <measurement group_id="O3" value="41.9" lower_limit="24.55" upper_limit="60.92"/>
                    <measurement group_id="O4" value="76.9" lower_limit="56.35" upper_limit="91.03"/>
                    <measurement group_id="O5" value="73.1" lower_limit="52.21" upper_limit="88.43"/>
                    <measurement group_id="O6" value="59.4" lower_limit="40.64" upper_limit="76.3"/>
                    <measurement group_id="O7" value="65.5" lower_limit="45.67" upper_limit="82.06"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="11.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV ConA1 gp140 (Clade A) IgA Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.0" lower_limit="16.56" upper_limit="46.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV ConA1 gp140 (Clade A) IgA Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.2" lower_limit="30.09" upper_limit="62.82"/>
                    <measurement group_id="O2" value="51.6" lower_limit="33.06" upper_limit="69.85"/>
                    <measurement group_id="O3" value="41.7" lower_limit="25.51" upper_limit="59.24"/>
                    <measurement group_id="O4" value="59.24" lower_limit="31.38" upper_limit="66.01"/>
                    <measurement group_id="O5" value="47.1" lower_limit="29.78" upper_limit="64.87"/>
                    <measurement group_id="O6" value="36.8" lower_limit="21.81" upper_limit="54.01"/>
                    <measurement group_id="O7" value="62.2" lower_limit="44.76" upper_limit="77.54"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 00MSA gp140 (Clade A) IgA Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.0" lower_limit="29.26" upper_limit="61.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV 00MSA gp140 (Clade A) IgA Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.4" lower_limit="39.62" upper_limit="72.19"/>
                    <measurement group_id="O2" value="64.5" lower_limit="45.37" upper_limit="80.77"/>
                    <measurement group_id="O3" value="41.7" lower_limit="25.51" upper_limit="59.24"/>
                    <measurement group_id="O4" value="51.4" lower_limit="33.99" upper_limit="68.62"/>
                    <measurement group_id="O5" value="52.9" lower_limit="35.13" upper_limit="70.22"/>
                    <measurement group_id="O6" value="47.4" lower_limit="30.98" upper_limit="64.18"/>
                    <measurement group_id="O7" value="48.6" lower_limit="31.92" upper_limit="65.6"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgA Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.0" lower_limit="2.79" upper_limit="23.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgA Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="36"/>
                    <count group_id="O4" value="35"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="37"/>
                    <count group_id="O8" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.7" lower_limit="32.42" upper_limit="65.22"/>
                    <measurement group_id="O2" value="29.0" lower_limit="14.22" upper_limit="48.04"/>
                    <measurement group_id="O3" value="11.1" lower_limit="3.11" upper_limit="26.06"/>
                    <measurement group_id="O4" value="42.9" lower_limit="26.32" upper_limit="60.65"/>
                    <measurement group_id="O5" value="32.4" lower_limit="17.39" upper_limit="50.53"/>
                    <measurement group_id="O6" value="7.9" lower_limit="1.66" upper_limit="21.38"/>
                    <measurement group_id="O7" value="37.8" lower_limit="22.46" upper_limit="55.24"/>
                    <measurement group_id="O8" value="2.6" lower_limit="0.07" upper_limit="13.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HIV ENV gp41 IgA Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="35"/>
                    <count group_id="O2" value="25"/>
                    <count group_id="O3" value="31"/>
                    <count group_id="O4" value="26"/>
                    <count group_id="O5" value="26"/>
                    <count group_id="O6" value="32"/>
                    <count group_id="O7" value="29"/>
                    <count group_id="O8" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.6" lower_limit="31.38" upper_limit="66.01"/>
                    <measurement group_id="O2" value="36.0" lower_limit="17.97" upper_limit="57.48"/>
                    <measurement group_id="O3" value="9.7" lower_limit="2.04" upper_limit="25.75"/>
                    <measurement group_id="O4" value="53.8" lower_limit="33.37" upper_limit="73.41"/>
                    <measurement group_id="O5" value="46.2" lower_limit="26.59" upper_limit="66.63"/>
                    <measurement group_id="O6" value="12.5" lower_limit="3.51" upper_limit="28.99"/>
                    <measurement group_id="O7" value="58.6" lower_limit="38.94" upper_limit="76.48"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="10.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (51802) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.7" lower_limit="57.21" upper_limit="85.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (51802) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.3" lower_limit="79.21" upper_limit="97.58"/>
                    <measurement group_id="O2" value="94.3" lower_limit="80.84" upper_limit="99.3"/>
                    <measurement group_id="O3" value="88.4" lower_limit="74.92" upper_limit="96.11"/>
                    <measurement group_id="O4" value="87.5" lower_limit="73.2" upper_limit="95.81"/>
                    <measurement group_id="O5" value="85.7" lower_limit="69.74" upper_limit="95.19"/>
                    <measurement group_id="O6" value="94.7" lower_limit="82.25" upper_limit="99.36"/>
                    <measurement group_id="O7" value="85.7" lower_limit="71.46" upper_limit="94.57"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (51802) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="87.2" lower_limit="72.57" upper_limit="95.7"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="86.8" lower_limit="71.91" upper_limit="95.59"/>
                    <measurement group_id="O7" value="90.9" lower_limit="75.67" upper_limit="98.08"/>
                    <measurement group_id="O8" value="5.6" lower_limit="0.68" upper_limit="18.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (51802) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.5" lower_limit="63.54" upper_limit="90.7"/>
                    <measurement group_id="O2" value="81.8" lower_limit="64.54" upper_limit="93.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (51802) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.4" lower_limit="51.35" upper_limit="82.5"/>
                    <measurement group_id="O2" value="74.2" lower_limit="55.39" upper_limit="88.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (254008) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.1" lower_limit="69.93" upper_limit="93.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (254008) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.1" lower_limit="76.43" upper_limit="96.38"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="88.4" lower_limit="74.92" upper_limit="96.11"/>
                    <measurement group_id="O4" value="85.0" lower_limit="70.16" upper_limit="94.29"/>
                    <measurement group_id="O5" value="85.7" lower_limit="69.74" upper_limit="95.19"/>
                    <measurement group_id="O6" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O7" value="88.1" lower_limit="74.37" upper_limit="96.02"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (254008) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="87.2" lower_limit="72.57" upper_limit="95.7"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O7" value="93.9" lower_limit="79.77" upper_limit="99.26"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (254008) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.4" lower_limit="86.52" upper_limit="99.94"/>
                    <measurement group_id="O2" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (254008) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="94.7" lower_limit="82.25" upper_limit="99.36"/>
                    <measurement group_id="O2" value="90.3" lower_limit="74.25" upper_limit="97.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (A244) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.0" lower_limit="59.66" upper_limit="86.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (A244) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.3" lower_limit="79.21" upper_limit="97.58"/>
                    <measurement group_id="O2" value="91.4" lower_limit="76.94" upper_limit="98.2"/>
                    <measurement group_id="O3" value="81.4" lower_limit="66.6" upper_limit="91.61"/>
                    <measurement group_id="O4" value="90.0" lower_limit="76.34" upper_limit="97.21"/>
                    <measurement group_id="O5" value="85.7" lower_limit="69.74" upper_limit="95.19"/>
                    <measurement group_id="O6" value="94.7" lower_limit="82.25" upper_limit="99.36"/>
                    <measurement group_id="O7" value="88.1" lower_limit="74.37" upper_limit="96.02"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (A244) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="89.7" lower_limit="75.78" upper_limit="97.13"/>
                    <measurement group_id="O4" value="91.2" lower_limit="76.32" upper_limit="98.14"/>
                    <measurement group_id="O5" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O6" value="89.5" lower_limit="75.2" upper_limit="97.06"/>
                    <measurement group_id="O7" value="90.9" lower_limit="75.67" upper_limit="98.08"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (A244) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.6" lower_limit="69.47" upper_limit="94.14"/>
                    <measurement group_id="O2" value="84.8" lower_limit="68.1" upper_limit="94.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (A244) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.1" lower_limit="54.1" upper_limit="84.58"/>
                    <measurement group_id="O2" value="71.0" lower_limit="51.96" upper_limit="85.78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (B.6240) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.4" lower_limit="72.65" upper_limit="94.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (B.6240) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7" lower_limit="85.16" upper_limit="99.47"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="97.7" lower_limit="87.71" upper_limit="99.94"/>
                    <measurement group_id="O4" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O5" value="85.7" lower_limit="69.74" upper_limit="95.19"/>
                    <measurement group_id="O6" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O7" value="90.5" lower_limit="77.38" upper_limit="97.34"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (B.6240) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="92.3" lower_limit="79.13" upper_limit="98.38"/>
                    <measurement group_id="O4" value="94.1" lower_limit="80.32" upper_limit="99.28"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O7" value="93.9" lower_limit="79.77" upper_limit="99.26"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (B.6240) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.6" lower_limit="69.47" upper_limit="94.14"/>
                    <measurement group_id="O2" value="93.9" lower_limit="79.77" upper_limit="99.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (B.6240) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.8" lower_limit="71.91" upper_limit="95.59"/>
                    <measurement group_id="O2" value="93.5" lower_limit="78.58" upper_limit="99.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (BORI) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.5" lower_limit="84.53" upper_limit="99.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (BORI) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7" lower_limit="85.16" upper_limit="99.47"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="93.0" lower_limit="80.94" upper_limit="98.54"/>
                    <measurement group_id="O4" value="90.0" lower_limit="76.34" upper_limit="97.21"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O7" value="90.5" lower_limit="77.38" upper_limit="97.34"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (BORI) IgG-t Ab at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="97.4" lower_limit="86.52" upper_limit="99.94"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O7" value="93.9" lower_limit="79.77" upper_limit="99.26"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (BORI) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.6" lower_limit="69.47" upper_limit="94.14"/>
                    <measurement group_id="O2" value="84.8" lower_limit="68.1" upper_limit="94.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (BORI) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.7" lower_limit="56.9" upper_limit="86.6"/>
                    <measurement group_id="O2" value="74.2" lower_limit="55.39" upper_limit="88.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (TT31P) gp120 IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.9" lower_limit="78.33" upper_limit="97.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (TT31P) gp120 IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7" lower_limit="85.16" upper_limit="99.47"/>
                    <measurement group_id="O2" value="91.4" lower_limit="76.94" upper_limit="98.2"/>
                    <measurement group_id="O3" value="90.7" lower_limit="77.86" upper_limit="97.41"/>
                    <measurement group_id="O4" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="88.1" lower_limit="74.37" upper_limit="96.02"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (TT31P) gp120 IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="94.9" lower_limit="82.68" upper_limit="99.37"/>
                    <measurement group_id="O4" value="94.1" lower_limit="80.32" upper_limit="99.28"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="90.9" lower_limit="75.67" upper_limit="98.08"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (TT31P) gp120 IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.2" lower_limit="72.57" upper_limit="95.7"/>
                    <measurement group_id="O2" value="93.9" lower_limit="79.77" upper_limit="99.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (TT31P) gp120 IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.8" lower_limit="71.91" upper_limit="95.59"/>
                    <measurement group_id="O2" value="87.1" lower_limit="70.17" upper_limit="96.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC (CNE20) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90.9" lower_limit="78.33" upper_limit="97.47"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC (CNE20) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.5" lower_limit="82.1" upper_limit="98.63"/>
                    <measurement group_id="O2" value="94.3" lower_limit="80.84" upper_limit="99.3"/>
                    <measurement group_id="O3" value="90.7" lower_limit="77.86" upper_limit="97.41"/>
                    <measurement group_id="O4" value="90.0" lower_limit="76.34" upper_limit="97.21"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O7" value="92.9" lower_limit="80.52" upper_limit="98.5"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC (CNE20) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="97.4" lower_limit="86.52" upper_limit="99.94"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="94.7" lower_limit="82.25" upper_limit="99.36"/>
                    <measurement group_id="O7" value="93.9" lower_limit="79.77" upper_limit="99.26"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC (CNE20) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.6" lower_limit="69.47" upper_limit="94.14"/>
                    <measurement group_id="O2" value="93.9" lower_limit="79.77" upper_limit="99.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC (CNE20) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.9" lower_limit="62.68" upper_limit="90.45"/>
                    <measurement group_id="O2" value="87.1" lower_limit="70.17" upper_limit="96.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC(BJOX002) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.0" lower_limit="59.66" upper_limit="86.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC(BJOX002) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.0" lower_limit="73.74" upper_limit="95.06"/>
                    <measurement group_id="O2" value="94.3" lower_limit="80.84" upper_limit="99.3"/>
                    <measurement group_id="O3" value="88.4" lower_limit="74.92" upper_limit="96.11"/>
                    <measurement group_id="O4" value="85.0" lower_limit="70.16" upper_limit="94.29"/>
                    <measurement group_id="O5" value="82.9" lower_limit="66.35" upper_limit="93.44"/>
                    <measurement group_id="O6" value="89.5" lower_limit="75.2" upper_limit="97.06"/>
                    <measurement group_id="O7" value="90.5" lower_limit="77.38" upper_limit="97.34"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC(BJOX002) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="89.7" lower_limit="75.78" upper_limit="97.13"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O6" value="94.7" lower_limit="82.25" upper_limit="99.36"/>
                    <measurement group_id="O7" value="93.9" lower_limit="79.77" upper_limit="99.26"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC(BJOX002) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.4" lower_limit="57.87" upper_limit="86.96"/>
                    <measurement group_id="O2" value="75.8" lower_limit="57.74" upper_limit="88.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC(BJOX002) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="68.4" lower_limit="51.35" upper_limit="82.5"/>
                    <measurement group_id="O2" value="74.2" lower_limit="55.39" upper_limit="88.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(1086C_D7) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.7" lower_limit="87.98" upper_limit="99.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(1086C_D7) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="92.29" upper_limit="100.0"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="100.0" lower_limit="91.78" upper_limit="100.0"/>
                    <measurement group_id="O4" value="97.5" lower_limit="86.84" upper_limit="99.94"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="90.75" lower_limit="83.84" upper_limit="99.42"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(1086C_D7) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(1086C_D7) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(1086C_D7) IgG-t Ab at Week 96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O2" value="96.8" lower_limit="83.3" upper_limit="99.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B Clade M (Con 6) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.7" lower_limit="87.98" upper_limit="99.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B Clade M (Con 6) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.8" lower_limit="88.47" upper_limit="99.94"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="97.7" lower_limit="87.71" upper_limit="99.94"/>
                    <measurement group_id="O4" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="92.9" lower_limit="80.52" upper_limit="98.5"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B Clade M (Con 6) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="97.4" lower_limit="86.52" upper_limit="99.94"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B Clade M (Con 6) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.4" lower_limit="86.52" upper_limit="99.94"/>
                    <measurement group_id="O2" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B Clade M (Con 6) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O2" value="93.5" lower_limit="78.58" upper_limit="99.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (SC42261) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.5" lower_limit="84.53" upper_limit="99.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (SC42261) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.8" lower_limit="88.47" upper_limit="99.94"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="100.0" lower_limit="91.78" upper_limit="100.0"/>
                    <measurement group_id="O4" value="95.0" lower_limit="83.08" upper_limit="99.39"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="95.2" lower_limit="83.84" upper_limit="99.42"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (SC42261) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (SC42261) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3" lower_limit="79.13" upper_limit="98.38"/>
                    <measurement group_id="O2" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (SC42261) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O2" value="93.5" lower_limit="78.58" upper_limit="99.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (CH505TF) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.6" lower_limit="75.44" upper_limit="96.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (CH505TF) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.5" lower_limit="82.1" upper_limit="98.63"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="93.0" lower_limit="80.94" upper_limit="98.54"/>
                    <measurement group_id="O4" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O5" value="85.7" lower_limit="69.74" upper_limit="95.19"/>
                    <measurement group_id="O6" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O7" value="95.2" lower_limit="83.84" upper_limit="99.42"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (CH505TF) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="92.3" lower_limit="79.13" upper_limit="98.38"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (CH505TF) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.2" lower_limit="68.75" upper_limit="93.98"/>
                    <measurement group_id="O2" value="90.9" lower_limit="75.67" upper_limit="98.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (CH505TF) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.6" lower_limit="65.67" upper_limit="92.26"/>
                    <measurement group_id="O2" value="77.4" lower_limit="58.9" upper_limit="90.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade A (9004S) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.1" lower_limit="69.93" upper_limit="93.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade A (9004S) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.3" lower_limit="79.21" upper_limit="97.58"/>
                    <measurement group_id="O2" value="94.3" lower_limit="80.84" upper_limit="99.3"/>
                    <measurement group_id="O3" value="90.7" lower_limit="77.86" upper_limit="97.41"/>
                    <measurement group_id="O4" value="90.0" lower_limit="76.34" upper_limit="97.21"/>
                    <measurement group_id="O5" value="85.7" lower_limit="69.74" upper_limit="95.19"/>
                    <measurement group_id="O6" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O7" value="88.1" lower_limit="74.37" upper_limit="96.02"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade A (9004S) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="94.9" lower_limit="82.68" upper_limit="99.37"/>
                    <measurement group_id="O4" value="100.0" lower_limit="89.72" upper_limit="100.0"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="93.9" lower_limit="79.77" upper_limit="99.26"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade A (9004S) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.2" lower_limit="72.57" upper_limit="95.7"/>
                    <measurement group_id="O2" value="84.8" lower_limit="68.1" upper_limit="94.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade A (9004S) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.8" lower_limit="71.91" upper_limit="95.59"/>
                    <measurement group_id="O2" value="87.1" lower_limit="70.17" upper_limit="96.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade B (RHPA) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.7" lower_limit="87.98" upper_limit="99.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade B (RHPA) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.8" lower_limit="88.47" upper_limit="99.94"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="100.0" lower_limit="91.78" upper_limit="100.0"/>
                    <measurement group_id="O4" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="95.2" lower_limit="83.84" upper_limit="99.42"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade B (RHPA) IgG-t Ab at Week 52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O8" value="2.8" lower_limit="0.07" upper_limit="14.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade B (RHPA) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3" lower_limit="79.13" upper_limit="98.38"/>
                    <measurement group_id="O2" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade B (RHPA) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O2" value="93.5" lower_limit="78.58" upper_limit="99.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade B (WITO) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.2" lower_limit="81.34" upper_limit="98.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade B (WITO) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.8" lower_limit="88.47" upper_limit="99.94"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="97.7" lower_limit="87.71" upper_limit="99.94"/>
                    <measurement group_id="O4" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="95.2" lower_limit="83.84" upper_limit="99.42"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade B (WITO) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="97.4" lower_limit="86.52" upper_limit="99.94"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade B (WITO) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.2" lower_limit="72.57" upper_limit="95.7"/>
                    <measurement group_id="O2" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade B (WITO) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O2" value="93.5" lower_limit="78.58" upper_limit="99.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade C (1086C) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.7" lower_limit="87.98" upper_limit="99.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade C (1086C) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="92.29" upper_limit="100.0"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="100.0" lower_limit="91.78" upper_limit="100.0"/>
                    <measurement group_id="O4" value="97.5" lower_limit="86.84" upper_limit="99.94"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="97.6" lower_limit="87.43" upper_limit="99.94"/>
                    <measurement group_id="O8" value="2.5" lower_limit="0.06" upper_limit="13.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade C (1086C) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade C (1086C) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade C (1086C) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O2" value="96.8" lower_limit="83.3" upper_limit="99.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade C (BF1266) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="93.2" lower_limit="81.34" upper_limit="98.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade C (BF1266) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7" lower_limit="85.16" upper_limit="99.47"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="97.7" lower_limit="87.71" upper_limit="99.94"/>
                    <measurement group_id="O4" value="92.5" lower_limit="79.61" upper_limit="98.43"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="92.9" lower_limit="80.52" upper_limit="98.5"/>
                    <measurement group_id="O8" value="2.5" lower_limit="0.06" upper_limit="13.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade C (BF1266) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O4" value="100.0" lower_limit="89.72" upper_limit="100.0"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O8" value="2.8" lower_limit="0.07" upper_limit="14.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade C (BF1266) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3" lower_limit="79.13" upper_limit="98.38"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>C Clade C (BF1266) IgG-t Ab at Week 96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O2" value="93.5" lower_limit="78.58" upper_limit="99.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CF Clade AE (conAE) IgG-t Ab at 16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88.6" lower_limit="75.44" upper_limit="96.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CF Clade AE (conAE) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7" lower_limit="85.16" upper_limit="99.47"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="93.0" lower_limit="80.94" upper_limit="98.54"/>
                    <measurement group_id="O4" value="90.0" lower_limit="76.34" upper_limit="97.21"/>
                    <measurement group_id="O5" value="85.7" lower_limit="69.74" upper_limit="95.19"/>
                    <measurement group_id="O6" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O7" value="95.2" lower_limit="83.84" upper_limit="99.42"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CF Clade AE (conAE) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="92.3" lower_limit="79.13" upper_limit="98.38"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="97.4" lower_limit="86.19" upper_limit="99.93"/>
                    <measurement group_id="O7" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CF Clade AE (conAE) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.3" lower_limit="79.13" upper_limit="98.38"/>
                    <measurement group_id="O2" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CF Clade AE (conAE) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.2" lower_limit="68.75" upper_limit="93.98"/>
                    <measurement group_id="O2" value="87.1" lower_limit="70.17" upper_limit="96.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CFI Clade M(Con S) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="97.7" lower_limit="87.98" upper_limit="99.94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CFI Clade M(Con S) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="92.29" upper_limit="100.0"/>
                    <measurement group_id="O2" value="97.1" lower_limit="85.08" upper_limit="99.93"/>
                    <measurement group_id="O3" value="100.0" lower_limit="91.78" upper_limit="100.0"/>
                    <measurement group_id="O4" value="97.5" lower_limit="86.84" upper_limit="99.94"/>
                    <measurement group_id="O5" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="97.6" lower_limit="87.43" upper_limit="99.94"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CFI Clade M(Con S) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O7" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CFI Clade M(Con S) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.97" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.42" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>CFI Clade M(Con S) IgG-t Ab at Week 96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.75" upper_limit="100.0"/>
                    <measurement group_id="O2" value="96.8" lower_limit="83.3" upper_limit="99.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.7" lower_limit="57.21" upper_limit="85.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95.7" lower_limit="85.16" upper_limit="99.47"/>
                    <measurement group_id="O2" value="88.6" lower_limit="73.26" upper_limit="96.8"/>
                    <measurement group_id="O3" value="79.1" lower_limit="63.96" upper_limit="89.96"/>
                    <measurement group_id="O4" value="87.5" lower_limit="73.2" upper_limit="95.81"/>
                    <measurement group_id="O5" value="85.7" lower_limit="69.74" upper_limit="95.19"/>
                    <measurement group_id="O6" value="89.5" lower_limit="75.2" upper_limit="97.06"/>
                    <measurement group_id="O7" value="90.5" lower_limit="77.38" upper_limit="97.34"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="100.0" lower_limit="90.51" upper_limit="100.0"/>
                    <measurement group_id="O2" value="100.0" lower_limit="89.11" upper_limit="100.0"/>
                    <measurement group_id="O3" value="89.7" lower_limit="75.78" upper_limit="97.13"/>
                    <measurement group_id="O4" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O5" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O6" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O7" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O8" value="5.6" lower_limit="0.68" upper_limit="18.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.2" lower_limit="72.57" upper_limit="95.7"/>
                    <measurement group_id="O2" value="81.8" lower_limit="64.54" upper_limit="93.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.6" lower_limit="65.67" upper_limit="92.26"/>
                    <measurement group_id="O2" value="67.7" lower_limit="48.63" upper_limit="83.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (191084) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.7" lower_limit="32.46" upper_limit="63.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (191084) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.2" lower_limit="49.75" upper_limit="78.65"/>
                    <measurement group_id="O2" value="45.7" lower_limit="28.83" upper_limit="63.35"/>
                    <measurement group_id="O3" value="46.5" lower_limit="31.18" upper_limit="62.35"/>
                    <measurement group_id="O4" value="60.0" lower_limit="43.33" upper_limit="75.14"/>
                    <measurement group_id="O5" value="42.9" lower_limit="26.32" upper_limit="60.65"/>
                    <measurement group_id="O6" value="47.4" lower_limit="30.98" upper_limit="64.18"/>
                    <measurement group_id="O7" value="38.1" lower_limit="23.57" upper_limit="54.36"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (191084) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.1" lower_limit="64.84" upper_limit="92.04"/>
                    <measurement group_id="O2" value="62.5" lower_limit="43.69" upper_limit="78.9"/>
                    <measurement group_id="O3" value="59.0" lower_limit="42.1" upper_limit="74.43"/>
                    <measurement group_id="O4" value="73.5" lower_limit="55.64" upper_limit="87.12"/>
                    <measurement group_id="O5" value="75.8" lower_limit="57.74" upper_limit="88.91"/>
                    <measurement group_id="O6" value="57.9" lower_limit="40.82" upper_limit="73.69"/>
                    <measurement group_id="O7" value="51.5" lower_limit="33.54" upper_limit="69.2"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (191084) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.2" lower_limit="15" upper_limit="44.87"/>
                    <measurement group_id="O2" value="18.2" lower_limit="6.98" upper_limit="35.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade A (191084) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.1" lower_limit="9.55" upper_limit="37.32"/>
                    <measurement group_id="O2" value="16.1" lower_limit="5.45" upper_limit="33.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (C2101) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.7" lower_limit="32.46" upper_limit="63.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (C2101) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.7" lower_limit="43.23" upper_limit="73"/>
                    <measurement group_id="O2" value="45.7" lower_limit="28.83" upper_limit="63.35"/>
                    <measurement group_id="O3" value="48.8" lower_limit="33.31" upper_limit="64.54"/>
                    <measurement group_id="O4" value="62.5" lower_limit="45.8" upper_limit="77.27"/>
                    <measurement group_id="O5" value="48.6" lower_limit="31.38" upper_limit="66.01"/>
                    <measurement group_id="O6" value="52.6" lower_limit="35.82" upper_limit="69.02"/>
                    <measurement group_id="O7" value="28.6" lower_limit="15.72" upper_limit="44.58"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (C2101) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.0" lower_limit="55.88" upper_limit="86.21"/>
                    <measurement group_id="O2" value="59.4" lower_limit="40.64" upper_limit="76.3"/>
                    <measurement group_id="O3" value="61.5" lower_limit="44.62" upper_limit="76.64"/>
                    <measurement group_id="O4" value="79.4" lower_limit="62.1" upper_limit="91.3"/>
                    <measurement group_id="O5" value="69.7" lower_limit="51.29" upper_limit="84.41"/>
                    <measurement group_id="O6" value="55.3" lower_limit="38.3" upper_limit="71.38"/>
                    <measurement group_id="O7" value="36.4" lower_limit="20.4" upper_limit="54.88"/>
                    <measurement group_id="O8" value="2.8" lower_limit="0.07" upper_limit="14.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (C2101) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.2" lower_limit="15" upper_limit="44.87"/>
                    <measurement group_id="O2" value="30.3" lower_limit="15.59" upper_limit="48.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (C2101) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.1" lower_limit="9.55" upper_limit="37.32"/>
                    <measurement group_id="O2" value="32.3" lower_limit="16.68" upper_limit="51.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (CM244) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.7" lower_limit="32.46" upper_limit="63.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (CM244) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.7" lower_limit="43.23" upper_limit="73"/>
                    <measurement group_id="O2" value="37.1" lower_limit="21.47" upper_limit="55.08"/>
                    <measurement group_id="O3" value="46.5" lower_limit="31.18" upper_limit="62.35"/>
                    <measurement group_id="O4" value="57.5" lower_limit="40.89" upper_limit="72.96"/>
                    <measurement group_id="O5" value="29.4" lower_limit="15.1" upper_limit="47.48"/>
                    <measurement group_id="O6" value="42.1" lower_limit="26.31" upper_limit="59.18"/>
                    <measurement group_id="O7" value="28.6" lower_limit="15.72" upper_limit="44.58"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (CM244) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.8" lower_limit="67.99" upper_limit="93.81"/>
                    <measurement group_id="O2" value="56.3" lower_limit="37.66" upper_limit="73.64"/>
                    <measurement group_id="O3" value="56.4" lower_limit="39.62" upper_limit="72.19"/>
                    <measurement group_id="O4" value="76.5" lower_limit="58.83" upper_limit="89.25"/>
                    <measurement group_id="O5" value="57.6" lower_limit="39.22" upper_limit="74.52"/>
                    <measurement group_id="O6" value="57.9" lower_limit="40.82" upper_limit="73.69"/>
                    <measurement group_id="O7" value="42.4" lower_limit="25.48" upper_limit="60.78"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (CM244) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.1" lower_limit="11.13" upper_limit="39.33"/>
                    <measurement group_id="O2" value="12.1" lower_limit="3.4" upper_limit="28.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade AE (CM244) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.1" lower_limit="9.55" upper_limit="37.32"/>
                    <measurement group_id="O2" value="16.1" lower_limit="5.45" upper_limit="33.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (62357.14) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.7" lower_limit="11.47" upper_limit="37.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (62357.14) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.3" lower_limit="27" upper_limit="56.77"/>
                    <measurement group_id="O2" value="17.1" lower_limit="6.56" upper_limit="33.65"/>
                    <measurement group_id="O3" value="16.3" lower_limit="6.81" upper_limit="30.7"/>
                    <measurement group_id="O4" value="37.5" lower_limit="22.73" upper_limit="54.2"/>
                    <measurement group_id="O5" value="20.0" lower_limit="8.44" upper_limit="36.94"/>
                    <measurement group_id="O6" value="23.7" lower_limit="11.44" upper_limit="40.24"/>
                    <measurement group_id="O7" value="19.0" lower_limit="8.6" upper_limit="34.12"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (62357.14) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.5" lower_limit="42.1" upper_limit="75.25"/>
                    <measurement group_id="O2" value="34.4" lower_limit="18.57" upper_limit="53.19"/>
                    <measurement group_id="O3" value="20.5" lower_limit="9.3" upper_limit="36.46"/>
                    <measurement group_id="O4" value="61.8" lower_limit="43.56" upper_limit="77.83"/>
                    <measurement group_id="O5" value="45.5" lower_limit="28.11" upper_limit="63.65"/>
                    <measurement group_id="O6" value="26.3" lower_limit="13.4" upper_limit="43.1"/>
                    <measurement group_id="O7" value="36.4" lower_limit="20.4" upper_limit="54.88"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (62357.14) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.5" lower_limit="9.3" upper_limit="36.46"/>
                    <measurement group_id="O2" value="9.1" lower_limit="1.92" upper_limit="24.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (62357.14) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.5" lower_limit="2.94" upper_limit="24.8"/>
                    <measurement group_id="O2" value="12.9" lower_limit="3.63" upper_limit="29.83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (CaseA) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.1" lower_limit="43.25" upper_limit="73.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (CaseA) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.4" lower_limit="51.98" upper_limit="80.47"/>
                    <measurement group_id="O2" value="51.4" lower_limit="33.99" upper_limit="68.62"/>
                    <measurement group_id="O3" value="62.8" lower_limit="46.73" upper_limit="77.02"/>
                    <measurement group_id="O4" value="65.0" lower_limit="48.32" upper_limit="79.37"/>
                    <measurement group_id="O5" value="42.9" lower_limit="26.32" upper_limit="60.65"/>
                    <measurement group_id="O6" value="63.2" lower_limit="45.99" upper_limit="78.19"/>
                    <measurement group_id="O7" value="45.2" lower_limit="29.85" upper_limit="61.33"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (CaseA) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.5" lower_limit="71.23" upper_limit="95.46"/>
                    <measurement group_id="O2" value="75.0" lower_limit="56.6" upper_limit="88.54"/>
                    <measurement group_id="O3" value="71.8" lower_limit="55.13" upper_limit="85"/>
                    <measurement group_id="O4" value="70.6" lower_limit="52.52" upper_limit="84.9"/>
                    <measurement group_id="O5" value="81.8" lower_limit="64.54" upper_limit="93.02"/>
                    <measurement group_id="O6" value="71.1" lower_limit="54.1" upper_limit="84.58"/>
                    <measurement group_id="O7" value="60.6" lower_limit="42.14" upper_limit="77.09"/>
                    <measurement group_id="O8" value="13.9" lower_limit="4.67" upper_limit="29.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (CaseA) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.1" lower_limit="26.31" upper_limit="59.18"/>
                    <measurement group_id="O2" value="30.3" lower_limit="15.59" upper_limit="48.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (CaseA) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.9" lower_limit="15.42" upper_limit="45.9"/>
                    <measurement group_id="O2" value="29.0" lower_limit="14.22" upper_limit="48.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (RHPA4259) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="34.56" upper_limit="65.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (RHPA4259) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.6" lower_limit="54.25" upper_limit="82.26"/>
                    <measurement group_id="O2" value="48.6" lower_limit="31.38" upper_limit="66.01"/>
                    <measurement group_id="O3" value="51.2" lower_limit="35.46" upper_limit="66.69"/>
                    <measurement group_id="O4" value="60.0" lower_limit="43.33" upper_limit="75.14"/>
                    <measurement group_id="O5" value="47.1" lower_limit="29.78" upper_limit="64.87"/>
                    <measurement group_id="O6" value="50.0" lower_limit="33.38" upper_limit="66.62"/>
                    <measurement group_id="O7" value="35.7" lower_limit="21.55" upper_limit="51.97"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (RHPA4259) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.8" lower_limit="67.99" upper_limit="93.81"/>
                    <measurement group_id="O2" value="59.4" lower_limit="40.64" upper_limit="76.3"/>
                    <measurement group_id="O3" value="59.0" lower_limit="42.1" upper_limit="74.43"/>
                    <measurement group_id="O4" value="67.6" lower_limit="49.47" upper_limit="82.61"/>
                    <measurement group_id="O5" value="75.8" lower_limit="57.74" upper_limit="88.91"/>
                    <measurement group_id="O6" value="57.9" lower_limit="40.82" upper_limit="73.69"/>
                    <measurement group_id="O7" value="48.5" lower_limit="30.8" upper_limit="66.46"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (RHPA4259) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="33.3" lower_limit="19.09" upper_limit="50.22"/>
                    <measurement group_id="O2" value="18.2" lower_limit="6.98" upper_limit="35.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (RHPA4259) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.9" lower_limit="15.42" upper_limit="45.9"/>
                    <measurement group_id="O2" value="22.6" lower_limit="9.59" upper_limit="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (TT31P) gp70 IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.1" lower_limit="43.25" upper_limit="73.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (TT31P) gp70 IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.6" lower_limit="54.25" upper_limit="82.26"/>
                    <measurement group_id="O2" value="45.7" lower_limit="28.83" upper_limit="63.35"/>
                    <measurement group_id="O3" value="51.2" lower_limit="35.46" upper_limit="66.69"/>
                    <measurement group_id="O4" value="62.5" lower_limit="45.8" upper_limit="77.27"/>
                    <measurement group_id="O5" value="37.1" lower_limit="21.47" upper_limit="55.08"/>
                    <measurement group_id="O6" value="50.0" lower_limit="33.38" upper_limit="66.62"/>
                    <measurement group_id="O7" value="50.0" lower_limit="34.19" upper_limit="65.81"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (TT31P) gp70 IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.5" lower_limit="71.23" upper_limit="95.46"/>
                    <measurement group_id="O2" value="62.5" lower_limit="43.69" upper_limit="78.9"/>
                    <measurement group_id="O3" value="66.7" lower_limit="49.78" upper_limit="80.91"/>
                    <measurement group_id="O4" value="73.5" lower_limit="55.64" upper_limit="87.12"/>
                    <measurement group_id="O5" value="75.8" lower_limit="57.74" upper_limit="88.91"/>
                    <measurement group_id="O6" value="57.9" lower_limit="40.82" upper_limit="73.69"/>
                    <measurement group_id="O7" value="57.6" lower_limit="39.22" upper_limit="74.52"/>
                    <measurement group_id="O8" value="2.8" lower_limit="0.07" upper_limit="14.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (TT31P) gp70 IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36.8" lower_limit="21.81" upper_limit="54.01"/>
                    <measurement group_id="O2" value="24.2" lower_limit="11.09" upper_limit="42.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B (TT31P) gp70 IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.6" lower_limit="17.5" upper_limit="48.65"/>
                    <measurement group_id="O2" value="22.6" lower_limit="9.59" upper_limit="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B(700010058) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50.0" lower_limit="34.56" upper_limit="65.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B(700010058) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.9" lower_limit="45.37" upper_limit="74.91"/>
                    <measurement group_id="O2" value="45.7" lower_limit="28.83" upper_limit="63.35"/>
                    <measurement group_id="O3" value="53.5" lower_limit="37.65" upper_limit="68.82"/>
                    <measurement group_id="O4" value="62.5" lower_limit="45.8" upper_limit="77.27"/>
                    <measurement group_id="O5" value="37.1" lower_limit="21.47" upper_limit="55.08"/>
                    <measurement group_id="O6" value="50.0" lower_limit="33.38" upper_limit="66.62"/>
                    <measurement group_id="O7" value="26.2" lower_limit="13.86" upper_limit="42.04"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B(700010058) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.9" lower_limit="47.46" upper_limit="79.79"/>
                    <measurement group_id="O2" value="62.5" lower_limit="43.69" upper_limit="78.9"/>
                    <measurement group_id="O3" value="64.1" lower_limit="47.18" upper_limit="78.8"/>
                    <measurement group_id="O4" value="70.6" lower_limit="52.52" upper_limit="84.9"/>
                    <measurement group_id="O5" value="66.7" lower_limit="48.17" upper_limit="82.04"/>
                    <measurement group_id="O6" value="57.9" lower_limit="40.82" upper_limit="73.69"/>
                    <measurement group_id="O7" value="33.3" lower_limit="17.96" upper_limit="51.83"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B(700010058) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.2" lower_limit="15" upper_limit="44.87"/>
                    <measurement group_id="O2" value="30.3" lower_limit="15.59" upper_limit="48.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade B(700010058) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="30"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="27.0" lower_limit="13.79" upper_limit="44.12"/>
                    <measurement group_id="O2" value="23.3" lower_limit="9.93" upper_limit="42.28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC (BJOX) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.3" lower_limit="36.69" upper_limit="67.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC (BJOX) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.4" lower_limit="51.98" upper_limit="80.47"/>
                    <measurement group_id="O2" value="48.6" lower_limit="31.38" upper_limit="66.01"/>
                    <measurement group_id="O3" value="55.8" lower_limit="39.88" upper_limit="70.92"/>
                    <measurement group_id="O4" value="62.5" lower_limit="45.8" upper_limit="77.27"/>
                    <measurement group_id="O5" value="40.0" lower_limit="23.87" upper_limit="57.89"/>
                    <measurement group_id="O6" value="47.4" lower_limit="30.98" upper_limit="64.18"/>
                    <measurement group_id="O7" value="35.7" lower_limit="21.55" upper_limit="51.97"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC (BJOX) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.1" lower_limit="64.84" upper_limit="92.04"/>
                    <measurement group_id="O2" value="62.5" lower_limit="43.69" upper_limit="78.9"/>
                    <measurement group_id="O3" value="66.7" lower_limit="49.78" upper_limit="80.91"/>
                    <measurement group_id="O4" value="70.6" lower_limit="52.52" upper_limit="84.9"/>
                    <measurement group_id="O5" value="66.7" lower_limit="48.17" upper_limit="82.04"/>
                    <measurement group_id="O6" value="60.5" lower_limit="43.39" upper_limit="75.96"/>
                    <measurement group_id="O7" value="54.5" lower_limit="36.35" upper_limit="71.89"/>
                    <measurement group_id="O8" value="2.8" lower_limit="0.07" upper_limit="14.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC (BJOX) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.1" lower_limit="11.13" upper_limit="39.33"/>
                    <measurement group_id="O2" value="18.2" lower_limit="6.98" upper_limit="35.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade BC (BJOX) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.1" lower_limit="9.55" upper_limit="37.32"/>
                    <measurement group_id="O2" value="22.6" lower_limit="9.59" upper_limit="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (96ZM651) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.6" lower_limit="5.17" upper_limit="27.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (96ZM651) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.3" lower_limit="15.99" upper_limit="43.46"/>
                    <measurement group_id="O2" value="17.1" lower_limit="6.56" upper_limit="33.65"/>
                    <measurement group_id="O3" value="4.7" lower_limit="0.57" upper_limit="15.81"/>
                    <measurement group_id="O4" value="32.5" lower_limit="18.57" upper_limit="49.13"/>
                    <measurement group_id="O5" value="20.0" lower_limit="8.44" upper_limit="36.94"/>
                    <measurement group_id="O6" value="18.4" lower_limit="7.74" upper_limit="34.33"/>
                    <measurement group_id="O7" value="14.3" lower_limit="5.43" upper_limit="28.54"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (96ZM651) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="54.1" lower_limit="36.92" upper_limit="70.51"/>
                    <measurement group_id="O2" value="40.6" lower_limit="23.7" upper_limit="59.36"/>
                    <measurement group_id="O3" value="20.5" lower_limit="9.3" upper_limit="36.46"/>
                    <measurement group_id="O4" value="61.8" lower_limit="43.56" upper_limit="77.83"/>
                    <measurement group_id="O5" value="36.4" lower_limit="20.4" upper_limit="54.88"/>
                    <measurement group_id="O6" value="36.8" lower_limit="21.81" upper_limit="54.01"/>
                    <measurement group_id="O7" value="30.3" lower_limit="15.59" upper_limit="48.71"/>
                    <measurement group_id="O8" value="2.8" lower_limit="0.07" upper_limit="14.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (96ZM651) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.3" lower_limit="2.87" upper_limit="24.22"/>
                    <measurement group_id="O2" value="9.1" lower_limit="1.92" upper_limit="24.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (96ZM651) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.5" lower_limit="2.94" upper_limit="24.8"/>
                    <measurement group_id="O2" value="6.5" lower_limit="0.79" upper_limit="21.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (BF1266) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.2" lower_limit="28.35" upper_limit="58.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (BF1266) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.7" lower_limit="43.23" upper_limit="73"/>
                    <measurement group_id="O2" value="31.4" lower_limit="16.85" upper_limit="49.29"/>
                    <measurement group_id="O3" value="30.2" lower_limit="17.18" upper_limit="46.13"/>
                    <measurement group_id="O4" value="50.0" lower_limit="33.8" upper_limit="66.2"/>
                    <measurement group_id="O5" value="34.3" lower_limit="19.13" upper_limit="52.21"/>
                    <measurement group_id="O6" value="34.2" lower_limit="19.63" upper_limit="51.35"/>
                    <measurement group_id="O7" value="31.0" lower_limit="17.62" upper_limit="47.09"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (BF1266) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.4" lower_limit="61.79" upper_limit="90.17"/>
                    <measurement group_id="O2" value="43.8" lower_limit="26.36" upper_limit="62.34"/>
                    <measurement group_id="O3" value="43.6" lower_limit="27.81" upper_limit="60.38"/>
                    <measurement group_id="O4" value="70.6" lower_limit="52.52" upper_limit="84.9"/>
                    <measurement group_id="O5" value="51.5" lower_limit="33.54" upper_limit="69.2"/>
                    <measurement group_id="O6" value="42.1" lower_limit="26.31" upper_limit="59.18"/>
                    <measurement group_id="O7" value="48.5" lower_limit="30.8" upper_limit="66.46"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (BF1266) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.9" lower_limit="7.54" upper_limit="33.53"/>
                    <measurement group_id="O2" value="18.2" lower_limit="6.98" upper_limit="35.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (BF1266) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.4" lower_limit="7.74" upper_limit="34.33"/>
                    <measurement group_id="O2" value="22.6" lower_limit="9.59" upper_limit="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (CAP210) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.1" lower_limit="20.49" upper_limit="49.92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (CAP210) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.8" lower_limit="32.89" upper_limit="63.05"/>
                    <measurement group_id="O2" value="42.9" lower_limit="26.32" upper_limit="60.65"/>
                    <measurement group_id="O3" value="32.6" lower_limit="19.08" upper_limit="48.54"/>
                    <measurement group_id="O4" value="50.0" lower_limit="33.8" upper_limit="66.2"/>
                    <measurement group_id="O5" value="25.7" lower_limit="12.49" upper_limit="43.26"/>
                    <measurement group_id="O6" value="21.1" lower_limit="9.55" upper_limit="37.32"/>
                    <measurement group_id="O7" value="26.2" lower_limit="13.86" upper_limit="42.04"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (CAP210) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.6" lower_limit="50.21" upper_limit="81.99"/>
                    <measurement group_id="O2" value="53.1" lower_limit="34.74" upper_limit="70.91"/>
                    <measurement group_id="O3" value="43.6" lower_limit="27.81" upper_limit="60.38"/>
                    <measurement group_id="O4" value="67.6" lower_limit="49.47" upper_limit="82.61"/>
                    <measurement group_id="O5" value="51.5" lower_limit="33.54" upper_limit="69.2"/>
                    <measurement group_id="O6" value="39.5" lower_limit="24.04" upper_limit="56.61"/>
                    <measurement group_id="O7" value="48.5" lower_limit="30.8" upper_limit="66.46"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (CAP210) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.6" lower_limit="13.04" upper_limit="42.13"/>
                    <measurement group_id="O2" value="18.2" lower_limit="6.98" upper_limit="35.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (CAP210) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.1" lower_limit="9.55" upper_limit="37.32"/>
                    <measurement group_id="O2" value="16.1" lower_limit="5.45" upper_limit="33.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(Ce1086) IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.7" lower_limit="32.46" upper_limit="63.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(Ce1086) IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.2" lower_limit="49.75" upper_limit="78.65"/>
                    <measurement group_id="O2" value="48.6" lower_limit="31.38" upper_limit="66.01"/>
                    <measurement group_id="O3" value="55.8" lower_limit="39.88" upper_limit="70.92"/>
                    <measurement group_id="O4" value="60.0" lower_limit="43.33" upper_limit="75.14"/>
                    <measurement group_id="O5" value="41.2" lower_limit="24.65" upper_limit="59.3"/>
                    <measurement group_id="O6" value="50.0" lower_limit="33.38" upper_limit="66.62"/>
                    <measurement group_id="O7" value="35.7" lower_limit="21.55" upper_limit="51.97"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(Ce1086) IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.1" lower_limit="64.84" upper_limit="92.04"/>
                    <measurement group_id="O2" value="65.6" lower_limit="46.81" upper_limit="81.43"/>
                    <measurement group_id="O3" value="64.1" lower_limit="47.18" upper_limit="78.8"/>
                    <measurement group_id="O4" value="85.3" lower_limit="68.94" upper_limit="95.05"/>
                    <measurement group_id="O5" value="72.7" lower_limit="54.48" upper_limit="86.7"/>
                    <measurement group_id="O6" value="68.4" lower_limit="51.35" upper_limit="82.5"/>
                    <measurement group_id="O7" value="54.5" lower_limit="36.35" upper_limit="71.89"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(Ce1086) IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.2" lower_limit="15" upper_limit="44.87"/>
                    <measurement group_id="O2" value="18.2" lower_limit="6.98" upper_limit="35.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(Ce1086) IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.7" lower_limit="11.44" upper_limit="40.24"/>
                    <measurement group_id="O2" value="22.6" lower_limit="9.59" upper_limit="41.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(TV1.21)IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.8" lower_limit="41.03" upper_limit="71.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(TV1.21)IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.3" lower_limit="63.64" upper_limit="89.05"/>
                    <measurement group_id="O2" value="54.3" lower_limit="36.65" upper_limit="71.17"/>
                    <measurement group_id="O3" value="48.8" lower_limit="33.31" upper_limit="64.54"/>
                    <measurement group_id="O4" value="62.5" lower_limit="45.8" upper_limit="77.27"/>
                    <measurement group_id="O5" value="48.6" lower_limit="31.38" upper_limit="66.01"/>
                    <measurement group_id="O6" value="39.5" lower_limit="24.04" upper_limit="56.61"/>
                    <measurement group_id="O7" value="50.0" lower_limit="34.19" upper_limit="65.81"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(TV1.21)IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.2" lower_limit="74.58" upper_limit="96.97"/>
                    <measurement group_id="O2" value="68.8" lower_limit="49.99" upper_limit="83.88"/>
                    <measurement group_id="O3" value="64.1" lower_limit="47.18" upper_limit="78.8"/>
                    <measurement group_id="O4" value="79.4" lower_limit="62.1" upper_limit="91.3"/>
                    <measurement group_id="O5" value="78.8" lower_limit="61.09" upper_limit="91.02"/>
                    <measurement group_id="O6" value="50.0" lower_limit="33.38" upper_limit="66.62"/>
                    <measurement group_id="O7" value="66.7" lower_limit="48.17" upper_limit="82.04"/>
                    <measurement group_id="O8" value="2.8" lower_limit="0.07" upper_limit="14.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(TV1.21)IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.5" lower_limit="23.36" upper_limit="55.38"/>
                    <measurement group_id="O2" value="27.3" lower_limit="13.3" upper_limit="45.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C(TV1.21)IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="30"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.7" lower_limit="15.87" upper_limit="46.98"/>
                    <measurement group_id="O2" value="26.7" lower_limit="12.28" upper_limit="45.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (001428)IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.5" lower_limit="30.39" upper_limit="61.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (001428)IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56.5" lower_limit="41.11" upper_limit="71.07"/>
                    <measurement group_id="O2" value="40.0" lower_limit="23.87" upper_limit="57.89"/>
                    <measurement group_id="O3" value="37.2" lower_limit="22.98" upper_limit="53.27"/>
                    <measurement group_id="O4" value="57.5" lower_limit="40.89" upper_limit="72.96"/>
                    <measurement group_id="O5" value="28.6" lower_limit="14.64" upper_limit="46.3"/>
                    <measurement group_id="O6" value="31.6" lower_limit="17.5" upper_limit="48.65"/>
                    <measurement group_id="O7" value="35.7" lower_limit="21.55" upper_limit="51.97"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (001428)IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.1" lower_limit="64.84" upper_limit="92.04"/>
                    <measurement group_id="O2" value="68.8" lower_limit="49.99" upper_limit="83.88"/>
                    <measurement group_id="O3" value="53.8" lower_limit="37.18" upper_limit="69.91"/>
                    <measurement group_id="O4" value="73.5" lower_limit="55.64" upper_limit="87.12"/>
                    <measurement group_id="O5" value="66.7" lower_limit="48.17" upper_limit="82.04"/>
                    <measurement group_id="O6" value="42.1" lower_limit="26.31" upper_limit="59.18"/>
                    <measurement group_id="O7" value="57.6" lower_limit="39.22" upper_limit="74.52"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (001428)IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35.0" lower_limit="20.63" upper_limit="51.68"/>
                    <measurement group_id="O2" value="25.0" lower_limit="11.46" upper_limit="43.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (001428)IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="30"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.2" lower_limit="15" upper_limit="44.87"/>
                    <measurement group_id="O2" value="26.7" lower_limit="12.28" upper_limit="45.89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (7060101641)IgG-t Ab at W16</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.7" lower_limit="32.46" upper_limit="63.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (7060101641)IgG-t Ab at W28</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="43"/>
                    <count group_id="O4" value="40"/>
                    <count group_id="O5" value="35"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="42"/>
                    <count group_id="O8" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="63.0" lower_limit="47.55" upper_limit="76.79"/>
                    <measurement group_id="O2" value="42.9" lower_limit="26.32" upper_limit="60.65"/>
                    <measurement group_id="O3" value="48.8" lower_limit="33.31" upper_limit="64.54"/>
                    <measurement group_id="O4" value="57.5" lower_limit="40.89" upper_limit="72.96"/>
                    <measurement group_id="O5" value="34.3" lower_limit="19.13" upper_limit="52.21"/>
                    <measurement group_id="O6" value="42.1" lower_limit="26.31" upper_limit="59.18"/>
                    <measurement group_id="O7" value="33.3" lower_limit="19.57" upper_limit="49.55"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="8.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (7060101641)IgG-t Ab at W52</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="37"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="34"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="81.1" lower_limit="64.84" upper_limit="92.04"/>
                    <measurement group_id="O2" value="62.5" lower_limit="43.69" upper_limit="78.9"/>
                    <measurement group_id="O3" value="59.0" lower_limit="42.1" upper_limit="74.43"/>
                    <measurement group_id="O4" value="67.6" lower_limit="49.47" upper_limit="82.61"/>
                    <measurement group_id="O5" value="66.7" lower_limit="48.17" upper_limit="82.04"/>
                    <measurement group_id="O6" value="44.7" lower_limit="28.62" upper_limit="61.7"/>
                    <measurement group_id="O7" value="51.5" lower_limit="33.54" upper_limit="69.2"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (7060101641)IgG-t Ab at W78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="33"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.5" lower_limit="23.36" upper_limit="55.38"/>
                    <measurement group_id="O2" value="15.2" lower_limit="5.11" upper_limit="31.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Clade C (7060101641)IgG-t Ab at W96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="38"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.4" lower_limit="7.74" upper_limit="34.33"/>
                    <measurement group_id="O2" value="16.1" lower_limit="5.45" upper_limit="33.73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percentage of Responders With Interferon-gamma (IFN-gamma) T Cell Responses Enzyme-linked Immunospot Assay (ELISpot)</title>
        <description>Frozen peripheral blood mononuclear cell (PBMCs) were analyzed by interferon-gamma (IFN-gamma) (ELISpot). The response was defined as post-baseline value &gt;P95 if baseline &lt;P95 or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=P95. The threshold for ELISpot test was based on the 95th percentile (P95) from the baseline values of participants on that test in the study. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
        <time_frame>Week 26, 50, 78 and 96</time_frame>
        <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
        <group_list>
          <group group_id="O1">
            <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
            <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O2">
            <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O3">
            <title>Group 3: Ad26/Ad26</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Group 4: Ad26/MVA + gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O5">
            <title>Group 5: Ad26/ MVA + gp140 LD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
          </group>
          <group group_id="O6">
            <title>Group 6: Ad26/MVA</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
          </group>
          <group group_id="O7">
            <title>Group 7: Ad26/ gp140 HD</title>
            <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
          </group>
          <group group_id="O8">
            <title>Group 8: Placebo/ Placebo</title>
            <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Responders With Interferon-gamma (IFN-gamma) T Cell Responses Enzyme-linked Immunospot Assay (ELISpot)</title>
          <description>Frozen peripheral blood mononuclear cell (PBMCs) were analyzed by interferon-gamma (IFN-gamma) (ELISpot). The response was defined as post-baseline value &gt;P95 if baseline &lt;P95 or missing or defined as post-baseline value &gt;3-fold increase from baseline if baseline &gt;=P95. The threshold for ELISpot test was based on the 95th percentile (P95) from the baseline values of participants on that test in the study. Samples taken after W48 from PPI set, who missed 4th vaccine or deviated schedule were excluded. As planned, the data reported for this endpoint at specified time points only for each reported category.</description>
          <population>PPI analysis set. Here 'N' (number of participants analyzed) signifies number of participants evaluable for this outcome measure. Here 'n' (number analyzed) signifies number of participants evaluable at specified time points.</population>
          <units>percentage of responders</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="47"/>
                <count group_id="O2" value="39"/>
                <count group_id="O3" value="45"/>
                <count group_id="O4" value="44"/>
                <count group_id="O5" value="43"/>
                <count group_id="O6" value="38"/>
                <count group_id="O7" value="43"/>
                <count group_id="O8" value="46"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ENV peptide pool Mos1 at Week (W) 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="91.5" lower_limit="79.62" upper_limit="97.63"/>
                    <measurement group_id="O2" value="79.5" lower_limit="63.54" upper_limit="90.7"/>
                    <measurement group_id="O3" value="75.0" lower_limit="59.66" upper_limit="86.81"/>
                    <measurement group_id="O4" value="95.5" lower_limit="84.53" upper_limit="99.44"/>
                    <measurement group_id="O5" value="97.7" lower_limit="87.71" upper_limit="99.94"/>
                    <measurement group_id="O6" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O7" value="86.0" lower_limit="72.07" upper_limit="94.7"/>
                    <measurement group_id="O8" value="4.3" lower_limit="0.53" upper_limit="14.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ENV peptide pool Mos1 at W 50</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="37"/>
                    <count group_id="O7" value="34"/>
                    <count group_id="O8" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.8" lower_limit="73.8" upper_limit="95.92"/>
                    <measurement group_id="O2" value="84.2" lower_limit="68.75" upper_limit="93.98"/>
                    <measurement group_id="O3" value="78.0" lower_limit="62.39" upper_limit="89.44"/>
                    <measurement group_id="O4" value="94.9" lower_limit="82.68" upper_limit="99.37"/>
                    <measurement group_id="O5" value="97.1" lower_limit="84.67" upper_limit="99.93"/>
                    <measurement group_id="O6" value="97.3" lower_limit="85.84" upper_limit="99.93"/>
                    <measurement group_id="O7" value="76.5" lower_limit="58.83" upper_limit="89.25"/>
                    <measurement group_id="O8" value="2.6" lower_limit="0.07" upper_limit="13.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ENV peptide pool Mos2 at W 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.3" lower_limit="57.36" upper_limit="84.38"/>
                    <measurement group_id="O2" value="41.0" lower_limit="25.57" upper_limit="57.9"/>
                    <measurement group_id="O3" value="34.1" lower_limit="20.49" upper_limit="49.92"/>
                    <measurement group_id="O4" value="72.7" lower_limit="57.21" upper_limit="85.04"/>
                    <measurement group_id="O5" value="72.1" lower_limit="56.33" upper_limit="84.67"/>
                    <measurement group_id="O6" value="71.1" lower_limit="54.1" upper_limit="84.58"/>
                    <measurement group_id="O7" value="53.5" lower_limit="37.65" upper_limit="68.82"/>
                    <measurement group_id="O8" value="2.2" lower_limit="0.06" upper_limit="11.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ENV peptide pool Mos2 at W 50</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="36"/>
                    <count group_id="O7" value="30"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.6" lower_limit="69.47" upper_limit="94.14"/>
                    <measurement group_id="O2" value="62.9" lower_limit="44.92" upper_limit="78.53"/>
                    <measurement group_id="O3" value="37.5" lower_limit="22.73" upper_limit="54.2"/>
                    <measurement group_id="O4" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O5" value="87.9" lower_limit="71.8" upper_limit="96.6"/>
                    <measurement group_id="O6" value="80.6" lower_limit="63.98" upper_limit="91.81"/>
                    <measurement group_id="O7" value="60.0" lower_limit="40.6" upper_limit="77.34"/>
                    <measurement group_id="O8" value="2.8" lower_limit="0.07" upper_limit="14.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ENV peptide pool potential T-cell epitopes(PTE)W26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.6" lower_limit="61.97" upper_limit="87.7"/>
                    <measurement group_id="O2" value="59.0" lower_limit="42.1" upper_limit="74.43"/>
                    <measurement group_id="O3" value="61.4" lower_limit="45.5" upper_limit="75.64"/>
                    <measurement group_id="O4" value="72.7" lower_limit="57.21" upper_limit="85.04"/>
                    <measurement group_id="O5" value="93.0" lower_limit="80.94" upper_limit="98.54"/>
                    <measurement group_id="O6" value="81.6" lower_limit="65.67" upper_limit="92.26"/>
                    <measurement group_id="O7" value="69.8" lower_limit="53.87" upper_limit="82.82"/>
                    <measurement group_id="O8" value="2.2" lower_limit="0.06" upper_limit="11.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ENV peptide pool PTE at W 50</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="37"/>
                    <count group_id="O7" value="34"/>
                    <count group_id="O8" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.5" lower_limit="65.13" upper_limit="91.18"/>
                    <measurement group_id="O2" value="63.2" lower_limit="45.99" upper_limit="78.19"/>
                    <measurement group_id="O3" value="58.5" lower_limit="42.11" upper_limit="73.68"/>
                    <measurement group_id="O4" value="79.5" lower_limit="63.54" upper_limit="90.7"/>
                    <measurement group_id="O5" value="88.2" lower_limit="72.55" upper_limit="96.7"/>
                    <measurement group_id="O6" value="81.1" lower_limit="64.84" upper_limit="92.04"/>
                    <measurement group_id="O7" value="67.6" lower_limit="49.47" upper_limit="82.61"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ENV peptide pool PTE at W 78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.0" lower_limit="44.5" upper_limit="75.8"/>
                    <measurement group_id="O2" value="50.0" lower_limit="32.92" upper_limit="67.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ENV peptide pool PTE at W 96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="25"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.1" lower_limit="47.18" upper_limit="78.8"/>
                    <measurement group_id="O2" value="40.6" lower_limit="23.7" upper_limit="59.36"/>
                    <measurement group_id="O3" value="40.0" lower_limit="21.13" upper_limit="61.33"/>
                    <measurement group_id="O4" value="50.0" lower_limit="28.22" upper_limit="71.78"/>
                    <measurement group_id="O5" value="73.9" lower_limit="51.59" upper_limit="89.77"/>
                    <measurement group_id="O6" value="62.5" lower_limit="40.59" upper_limit="81.2"/>
                    <measurement group_id="O7" value="47.6" lower_limit="25.71" upper_limit="70.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gag peptide pool Mos1 at W 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.7" lower_limit="30.17" upper_limit="59.88"/>
                    <measurement group_id="O2" value="38.5" lower_limit="23.36" upper_limit="55.38"/>
                    <measurement group_id="O3" value="36.4" lower_limit="22.41" upper_limit="52.23"/>
                    <measurement group_id="O4" value="54.5" lower_limit="38.85" upper_limit="69.61"/>
                    <measurement group_id="O5" value="55.8" lower_limit="39.88" upper_limit="70.92"/>
                    <measurement group_id="O6" value="50.0" lower_limit="33.38" upper_limit="66.62"/>
                    <measurement group_id="O7" value="34.9" lower_limit="21.01" upper_limit="50.93"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gag peptide pool Mos1 at W 50</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="38"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="39"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="36"/>
                    <count group_id="O7" value="34"/>
                    <count group_id="O8" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.3" lower_limit="30.66" upper_limit="62.58"/>
                    <measurement group_id="O2" value="47.4" lower_limit="30.98" upper_limit="64.18"/>
                    <measurement group_id="O3" value="24.4" lower_limit="12.36" upper_limit="40.3"/>
                    <measurement group_id="O4" value="61.5" lower_limit="44.62" upper_limit="76.64"/>
                    <measurement group_id="O5" value="73.5" lower_limit="55.64" upper_limit="87.12"/>
                    <measurement group_id="O6" value="61.1" lower_limit="43.46" upper_limit="76.86"/>
                    <measurement group_id="O7" value="23.5" lower_limit="10.75" upper_limit="41.17"/>
                    <measurement group_id="O8" value="2.6" lower_limit="0.07" upper_limit="13.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gag peptide pool Mos2 at W 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.9" lower_limit="34.08" upper_limit="63.94"/>
                    <measurement group_id="O2" value="35.9" lower_limit="21.2" upper_limit="52.82"/>
                    <measurement group_id="O3" value="43.2" lower_limit="28.35" upper_limit="58.97"/>
                    <measurement group_id="O4" value="56.8" lower_limit="41.03" upper_limit="71.65"/>
                    <measurement group_id="O5" value="55.8" lower_limit="39.88" upper_limit="70.92"/>
                    <measurement group_id="O6" value="68.4" lower_limit="51.35" upper_limit="82.5"/>
                    <measurement group_id="O7" value="39.5" lower_limit="24.98" upper_limit="55.59"/>
                    <measurement group_id="O8" value="2.2" lower_limit="0.06" upper_limit="11.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gag peptide pool Mos2 at W 50</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="40"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="36"/>
                    <count group_id="O7" value="30"/>
                    <count group_id="O8" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.0" lower_limit="42.1" upper_limit="74.43"/>
                    <measurement group_id="O2" value="47.1" lower_limit="29.78" upper_limit="64.87"/>
                    <measurement group_id="O3" value="35.0" lower_limit="20.63" upper_limit="51.68"/>
                    <measurement group_id="O4" value="71.1" lower_limit="54.1" upper_limit="84.58"/>
                    <measurement group_id="O5" value="78.8" lower_limit="61.09" upper_limit="91.02"/>
                    <measurement group_id="O6" value="66.7" lower_limit="49.03" upper_limit="81.44"/>
                    <measurement group_id="O7" value="43.3" lower_limit="25.46" upper_limit="62.57"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gag peptide pool PTE at W 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.3" lower_limit="24.51" upper_limit="53.62"/>
                    <measurement group_id="O2" value="30.8" lower_limit="17.02" upper_limit="47.57"/>
                    <measurement group_id="O3" value="38.6" lower_limit="24.36" upper_limit="54.5"/>
                    <measurement group_id="O4" value="47.7" lower_limit="32.46" upper_limit="63.31"/>
                    <measurement group_id="O5" value="55.8" lower_limit="39.88" upper_limit="70.92"/>
                    <measurement group_id="O6" value="50.0" lower_limit="33.38" upper_limit="66.62"/>
                    <measurement group_id="O7" value="30.2" lower_limit="17.18" upper_limit="46.13"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gag peptide pool PTE at W 50</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="36"/>
                    <count group_id="O7" value="32"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.6" lower_limit="27.81" upper_limit="60.38"/>
                    <measurement group_id="O2" value="47.2" lower_limit="30.41" upper_limit="64.51"/>
                    <measurement group_id="O3" value="34.1" lower_limit="20.08" upper_limit="50.59"/>
                    <measurement group_id="O4" value="50.0" lower_limit="33.38" upper_limit="66.62"/>
                    <measurement group_id="O5" value="64.7" lower_limit="46.49" upper_limit="80.25"/>
                    <measurement group_id="O6" value="63.9" lower_limit="46.22" upper_limit="79.18"/>
                    <measurement group_id="O7" value="21.9" lower_limit="9.28" upper_limit="39.97"/>
                    <measurement group_id="O8" value="5.6" lower_limit="0.68" upper_limit="18.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gag peptide pool PTE at W 78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29.3" lower_limit="16.13" upper_limit="45.54"/>
                    <measurement group_id="O2" value="33.3" lower_limit="18.56" upper_limit="50.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Gag peptide pool PTE at W 96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="25"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.5" lower_limit="9.3" upper_limit="36.46"/>
                    <measurement group_id="O2" value="25.0" lower_limit="11.46" upper_limit="43.4"/>
                    <measurement group_id="O3" value="20.0" lower_limit="6.83" upper_limit="40.7"/>
                    <measurement group_id="O4" value="27.3" lower_limit="10.73" upper_limit="50.22"/>
                    <measurement group_id="O5" value="30.4" lower_limit="13.21" upper_limit="52.92"/>
                    <measurement group_id="O6" value="33.3" lower_limit="15.63" upper_limit="55.32"/>
                    <measurement group_id="O7" value="23.8" lower_limit="8.22" upper_limit="47.17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pol peptide pool Mos1 at W 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.9" lower_limit="66.74" upper_limit="90.85"/>
                    <measurement group_id="O2" value="53.8" lower_limit="37.18" upper_limit="69.91"/>
                    <measurement group_id="O3" value="56.8" lower_limit="41.03" upper_limit="71.65"/>
                    <measurement group_id="O4" value="70.5" lower_limit="54.8" upper_limit="83.24"/>
                    <measurement group_id="O5" value="81.4" lower_limit="66.6" upper_limit="91.61"/>
                    <measurement group_id="O6" value="89.5" lower_limit="75.2" upper_limit="97.06"/>
                    <measurement group_id="O7" value="58.1" lower_limit="42.13" upper_limit="72.99"/>
                    <measurement group_id="O8" value="4.3" lower_limit="0.53" upper_limit="14.84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pol peptide pool Mos1 at W 50</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="40"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="34"/>
                    <count group_id="O6" value="36"/>
                    <count group_id="O7" value="33"/>
                    <count group_id="O8" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72.5" lower_limit="56.11" upper_limit="85.4"/>
                    <measurement group_id="O2" value="55.6" lower_limit="38.1" upper_limit="72.06"/>
                    <measurement group_id="O3" value="65.9" lower_limit="49.41" upper_limit="79.92"/>
                    <measurement group_id="O4" value="76.3" lower_limit="59.76" upper_limit="88.56"/>
                    <measurement group_id="O5" value="85.3" lower_limit="68.94" upper_limit="95.05"/>
                    <measurement group_id="O6" value="91.7" lower_limit="77.53" upper_limit="98.25"/>
                    <measurement group_id="O7" value="39.4" lower_limit="22.91" upper_limit="57.86"/>
                    <measurement group_id="O8" value="2.6" lower_limit="0.07" upper_limit="13.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pol peptide pool Mos2 at W 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.1" lower_limit="71.69" upper_limit="93.8"/>
                    <measurement group_id="O2" value="76.9" lower_limit="60.67" upper_limit="88.87"/>
                    <measurement group_id="O3" value="68.2" lower_limit="52.42" upper_limit="81.39"/>
                    <measurement group_id="O4" value="79.5" lower_limit="64.7" upper_limit="90.2"/>
                    <measurement group_id="O5" value="86.0" lower_limit="72.07" upper_limit="94.7"/>
                    <measurement group_id="O6" value="94.7" lower_limit="82.25" upper_limit="99.36"/>
                    <measurement group_id="O7" value="69.8" lower_limit="53.87" upper_limit="82.82"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pol peptide pool Mos2 at W 50</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="34"/>
                    <count group_id="O3" value="39"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="36"/>
                    <count group_id="O7" value="29"/>
                    <count group_id="O8" value="35"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.6" lower_limit="69.47" upper_limit="94.14"/>
                    <measurement group_id="O2" value="70.6" lower_limit="52.52" upper_limit="84.9"/>
                    <measurement group_id="O3" value="79.5" lower_limit="63.54" upper_limit="90.7"/>
                    <measurement group_id="O4" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O5" value="97.0" lower_limit="84.24" upper_limit="99.92"/>
                    <measurement group_id="O6" value="100.0" lower_limit="90.26" upper_limit="100"/>
                    <measurement group_id="O7" value="55.2" lower_limit="35.69" upper_limit="73.55"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pol peptide pool PTE at W 26</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="39"/>
                    <count group_id="O3" value="44"/>
                    <count group_id="O4" value="44"/>
                    <count group_id="O5" value="43"/>
                    <count group_id="O6" value="38"/>
                    <count group_id="O7" value="43"/>
                    <count group_id="O8" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.0" lower_limit="69.19" upper_limit="92.35"/>
                    <measurement group_id="O2" value="56.4" lower_limit="39.62" upper_limit="72.19"/>
                    <measurement group_id="O3" value="61.4" lower_limit="45.5" upper_limit="75.64"/>
                    <measurement group_id="O4" value="68.2" lower_limit="52.42" upper_limit="81.39"/>
                    <measurement group_id="O5" value="86.0" lower_limit="72.07" upper_limit="94.7"/>
                    <measurement group_id="O6" value="92.1" lower_limit="78.62" upper_limit="98.34"/>
                    <measurement group_id="O7" value="67.4" lower_limit="51.46" upper_limit="80.92"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="7.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pol peptide pool PTE at W 50</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="35"/>
                    <count group_id="O3" value="41"/>
                    <count group_id="O4" value="38"/>
                    <count group_id="O5" value="33"/>
                    <count group_id="O6" value="36"/>
                    <count group_id="O7" value="32"/>
                    <count group_id="O8" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="82.1" lower_limit="66.47" upper_limit="92.46"/>
                    <measurement group_id="O2" value="54.3" lower_limit="36.65" upper_limit="71.17"/>
                    <measurement group_id="O3" value="73.2" lower_limit="57.06" upper_limit="85.78"/>
                    <measurement group_id="O4" value="86.8" lower_limit="71.91" upper_limit="95.59"/>
                    <measurement group_id="O5" value="90.9" lower_limit="75.67" upper_limit="98.08"/>
                    <measurement group_id="O6" value="94.4" lower_limit="81.34" upper_limit="99.32"/>
                    <measurement group_id="O7" value="53.1" lower_limit="34.74" upper_limit="70.91"/>
                    <measurement group_id="O8" value="0" lower_limit="0" upper_limit="9.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pol peptide pool PTE at W 78</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="41"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="0"/>
                    <count group_id="O5" value="0"/>
                    <count group_id="O6" value="0"/>
                    <count group_id="O7" value="0"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="78.0" lower_limit="62.39" upper_limit="89.44"/>
                    <measurement group_id="O2" value="52.8" lower_limit="35.49" upper_limit="69.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Pol peptide pool PTE at W 96</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="39"/>
                    <count group_id="O2" value="32"/>
                    <count group_id="O3" value="25"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="23"/>
                    <count group_id="O6" value="24"/>
                    <count group_id="O7" value="21"/>
                    <count group_id="O8" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.8" lower_limit="55.13" upper_limit="85"/>
                    <measurement group_id="O2" value="40.6" lower_limit="23.7" upper_limit="59.36"/>
                    <measurement group_id="O3" value="60.0" lower_limit="38.67" upper_limit="78.87"/>
                    <measurement group_id="O4" value="36.4" lower_limit="17.2" upper_limit="59.34"/>
                    <measurement group_id="O5" value="56.5" lower_limit="34.49" upper_limit="76.81"/>
                    <measurement group_id="O6" value="62.5" lower_limit="40.59" upper_limit="81.2"/>
                    <measurement group_id="O7" value="33.3" lower_limit="14.59" upper_limit="56.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Serious adverse events (SAEs) are reported for entire study period up to Week 96 and other AEs are reported for treatment period up to Week 52.</time_frame>
      <desc>The full analysis set (FAS) included all randomized participants with at least one study vaccine administration documented regardless of the occurrence of protocol deviations.</desc>
      <group_list>
        <group group_id="E1">
          <title>Group 1: Ad26/Ad26 + gp140 High Dose (HD)</title>
          <description>Participants received 5*10^10 viral particle (vp) of adenovirus serotype 26- Mosaic -Human Immunodeficiency Virus (Ad26.Mos.HIV) Intramuscular (IM) vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and HIV type 1 Clade C glycoprotein 140 drug product (gp140 DP) IM high dose vaccine containing 250 microgram (mcg) of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
        </group>
        <group group_id="E2">
          <title>Group 2: Ad26/Ad26 + gp140 Low Dose (LD)</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV vaccine and gp140 DP IM low dose vaccine containing 50 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
        </group>
        <group group_id="E3">
          <title>Group 3: Ad26/Ad26</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 5*10^10 vp Ad26.Mos.HIV IM vaccine and matched placebo IM vaccine.</description>
        </group>
        <group group_id="E4">
          <title>Group 4: Ad26/MVA + gp140 HD</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 plaque-forming unit (pfu) modified Vaccinia Ankara (MVA)-Mosaic IM vaccine and gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
        </group>
        <group group_id="E5">
          <title>Group 5: Ad26/ MVA + gp140 LD</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and gp140 DP IM low dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant.</description>
        </group>
        <group group_id="E6">
          <title>Group 6: Ad26/MVA</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received 10^8 pfu MVA-Mosaic IM vaccine and matched placebo IM vaccine.</description>
        </group>
        <group group_id="E7">
          <title>Group 7: Ad26/ gp140 HD</title>
          <description>Participants received 5*10^10 vp of Ad26.Mos.HIV IM vaccine at Week 0 and 12. At Week 24 and 48, participants received gp140 DP IM high dose vaccine containing 250 mcg of total glycoprotein mixed with adjuvant (aluminum phosphate).</description>
        </group>
        <group group_id="E8">
          <title>Group 8: Placebo/ Placebo</title>
          <description>Participants received matched placebo sterile 0.9% saline IM vaccine at Week 0, 12, 24 and 48.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA Version 19.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Local swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>HIV infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tonsillitis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tubo-ovarian abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Stab wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Lumbar vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Intraductal proliferative breast lesion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Blighted ovum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Complication of pregnancy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Foetal death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Adjustment disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Generalised anxiety disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Pregnancy of partner</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA Version 19.0</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="50" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="48" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="48" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="47" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="47" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="46" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="47" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="46" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Hypochromic anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Neutropenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrioventricular block first degree</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Bundle branch block right</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Conduction disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Deafness unilateral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Thyroid mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blepharitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Conjunctivitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Eye irritation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Eye pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Eye swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Eyelid pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Hypermetropia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Ocular discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Photophobia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Abdominal tenderness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dental caries</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Flatulence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Lip blister</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Mouth ulceration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="12" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="11" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="8" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Salivary hypersecretion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tongue dry</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tooth impacted</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="21" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="18" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="18" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="12" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Face oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="23" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="26" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="25" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="24" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="26" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="22" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="20" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Feeling cold</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Feeling hot</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site bruising</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="44" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="37" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="34" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="37" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="36" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="38" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="35" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="24" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="18" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="15" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="12" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="13" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tenderness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Axillary pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Induration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Infusion site pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site discolouration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="7" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="10" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site induration</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site pruritus</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="11" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="9" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="7" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="7" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Injection site warmth</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="8" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="8" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="10" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="8" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Swelling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Vaccination site joint discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic reaction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Food allergy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Acarodermatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Acute HIV infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Acute sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Amoebiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Ascariasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Bacterial vaginosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Body tinea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Candida infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Chlamydial infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Cystitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dermatitis infected</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Fungal skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Genital herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Gingivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Gonorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Herpes simplex</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Hookworm infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Hordeolum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="5" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Malaria</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Oophoritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Oral herpes</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Otitis externa</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Parasitic gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pulpitis dental</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pyuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rash pustular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rhinitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Syphilis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tinea infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tinea versicolour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tonsillitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tooth abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Tooth infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Trichomoniasis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Typhoid fever</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="6" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="7" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="9" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Urethritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Urethritis chlamydial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="5" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Urogenital trichomoniasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Varicella</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Viral upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Vulvovaginal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Vulvovaginal mycotic infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Vulvovaginitis trichomonal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Gun shot wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Limb injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Muscle contusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Procedural dizziness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Procedural headache</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="5" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Soft tissue injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Stress fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Thermal burn</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Wound</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Procedural nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Procedural vomiting</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Alanine aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Blood creatine increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Blood creatinine decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Blood pressure diastolic increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Blood pressure systolic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Blood pressure systolic increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Blood urine present</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Electrocardiogram QT prolonged</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Eosinophil percentage increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Neutrophil count decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Platelet count decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Protein urine</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Red blood cells urine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>White blood cells urine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Body temperature increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Abnormal loss of weight</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="15" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="11" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="19" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="11" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="11" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="10" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="20" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="20" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="17" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="20" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="24" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="16" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="16" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Burning sensation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dizziness exertional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dysgeusia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="32" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="26" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="28" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="26" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="23" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="20" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Hyperaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Parosmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Libido disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Chronic kidney disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Ketonuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="6" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Renal impairment</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Balanoposthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Breast tenderness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Erectile dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Genital discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Genital rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Genital ulceration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Menorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Metrorrhagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Premenstrual syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Vaginal discharge</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Allergic sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dry throat</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rhinalgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rhinitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Sneezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Acne</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Cold sweat</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dermatitis allergic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dermatitis atopic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dermatosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Eczema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Night sweats</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rash generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rash papular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="4" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="7" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rash macular</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Pregnancy of partner</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Systolic hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="49"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>A copy of the manuscript must be provided to the sponsor for review at least 60 days before submission for publication or presentation. If requested in writing, such publication will be withheld for up to an additional 60 days.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Director</name_or_title>
      <organization>Janssen Vaccines &amp; Prevention B.V.</organization>
      <phone>844-434-4210</phone>
      <email>ClinicalTrialDisclosure@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

